PL2399990T3 - Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia - Google Patents

Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia

Info

Publication number: PL2399990T3
Authority: PL; Poland
Prior art keywords: partum; heart; disease; post; treatment
Prior art date: 2003-06-27

Application number

PL10183053T

Other languages

English (en)

Inventor

Ian Ross Harris

Alexander M Harmon

Anthony J Kihm

Darin J Messina

Sanjay Mistry

Agnieszka Seyda

Chin-Feng Yi

Anna Gosiewska

Original Assignee

Depuy Synthes Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-27

Filing date

2004-06-25

Publication date

2015-12-31

2004-06-25 Application filed by Depuy Synthes Products Inc filed Critical Depuy Synthes Products Inc

2015-12-31 Publication of PL2399990T3 publication Critical patent/PL2399990T3/pl

Links

201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
210000003954 umbilical cord Anatomy 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Neurology (AREA)
Cell Biology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)

PL10183053T 2003-06-27 2004-06-25 Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia PL2399990T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US48326403P	2003-06-27	2003-06-27
EP04777287.6A EP1641918B1 (en)	2003-06-27	2004-06-25	Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
EP10183053.7A EP2399990B1 (en)	2003-06-27	2004-06-25	Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system

Publications (1)

Publication Number	Publication Date
PL2399990T3 true PL2399990T3 (pl)	2015-12-31

Family

ID=38456561

Family Applications (14)

Application Number	Title	Priority Date	Filing Date
PL10184137T PL2338980T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem poporodowych komórek pępowinowych
PL10183053T PL2399990T3 (pl)	2003-06-27	2004-06-25	Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia
PL10184796T PL2336298T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04809466T PL1649013T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych
PL04777286.8T PL1641917T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek miękkich przy zastosowaniu komórek pozyskiwanych poporodowo
PL04777287T PL1641918T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
PL10183911T PL2341131T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanki chrzęstnej i kostnej z wykorzystaniem komórek uzyskanych po porodzie
PL04777231T PL1641914T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL10184306T PL2338982T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL04777234T PL1641915T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo
PL04756395T PL1641913T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10184221T PL2338981T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek pochodzących z pępowiny poporodowej
PL10184593T PL2322599T3 (pl)	2003-06-27	2004-06-25	Komórki pozyskiwane poporodowo z tkanki sznura pępowinowego i sposoby pozyskiwania i zastosowania tych komórek do naprawy i regeneracji tkanek miękkich
PL04777235T PL1641916T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL10184137T PL2338980T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem poporodowych komórek pępowinowych

Family Applications After (12)

Application Number	Title	Priority Date	Filing Date
PL10184796T PL2336298T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04809466T PL1649013T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych
PL04777286.8T PL1641917T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek miękkich przy zastosowaniu komórek pozyskiwanych poporodowo
PL04777287T PL1641918T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
PL10183911T PL2341131T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanki chrzęstnej i kostnej z wykorzystaniem komórek uzyskanych po porodzie
PL04777231T PL1641914T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL10184306T PL2338982T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL04777234T PL1641915T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo
PL04756395T PL1641913T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10184221T PL2338981T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek pochodzących z pępowiny poporodowej
PL10184593T PL2322599T3 (pl)	2003-06-27	2004-06-25	Komórki pozyskiwane poporodowo z tkanki sznura pępowinowego i sposoby pozyskiwania i zastosowania tych komórek do naprawy i regeneracji tkanek miękkich
PL04777235T PL1641916T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych

Country Status (8)

Country	Link
US (28)	US9579351B2 (pl)
EP (14)	EP2338982B1 (pl)
JP (7)	JP5148873B2 (pl)
AU (7)	AU2004252567B2 (pl)
CA (7)	CA2530732C (pl)
ES (14)	ES2552226T3 (pl)
PL (14)	PL2338980T3 (pl)
WO (7)	WO2005001077A2 (pl)

Families Citing this family (577)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080077251A1 (en) *	1999-06-07	2008-03-27	Chen Silvia S	Cleaning and devitalization of cartilage
US8563232B2 (en)	2000-09-12	2013-10-22	Lifenet Health	Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US20020095157A1 (en) *	1999-07-23	2002-07-18	Bowman Steven M.	Graft fixation device combination
US6179840B1 (en)	1999-07-23	2001-01-30	Ethicon, Inc.	Graft fixation device and method
US8147824B2 (en)	1999-08-05	2012-04-03	Athersys, Inc.	Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US7311905B2 (en) *	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
DK1349918T3 (da)	2000-12-06	2014-11-10	Anthrogenesis Corp	Fremgangsmåde til indsamling af stamceller fra moderkagen
US7311904B2 (en) *	2001-02-14	2007-12-25	Anthrogenesis Corporation	Tissue matrices comprising placental stem cells, and methods of making the same
CA2365376C (en)	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
IL157350A0 (en) *	2001-02-14	2004-02-19	Anthrogenesis Corp	Post-partum mammalian placenta, its use and placental stem cells therefrom
WO2003008535A2 (en) *	2001-07-20	2003-01-30	Technion Research And Development Foundation Ltd.	Methods of generating human cardiac cells and tissues and uses thereof
US7677565B2 (en)	2001-09-28	2010-03-16	Shuffle Master, Inc	Card shuffler with card rank and value reading capability
US7736892B2 (en)	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
US20080299090A1 (en) *	2002-02-25	2008-12-04	Kansas State University Research Foundation	Use Of Umbilical Cord Matrix Cells
US20080003258A1 (en) *	2002-10-16	2008-01-03	Marcum Frank D	Composition and Method for Treating Rheumatoid Arthritis
US7824701B2 (en) *	2002-10-18	2010-11-02	Ethicon, Inc.	Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en) *	2002-10-18	2004-04-22	Francois Binette	Biocompatible scaffolds with tissue fragments
JP2006509770A (ja) *	2002-11-26	2006-03-23	アンソロジェネシスコーポレーション	細胞治療学、細胞治療単位、およびそれらを利用した治療法
WO2004069172A2 (en)	2003-01-30	2004-08-19	The Government of the United States of America as represented by the Department of Veterans Affairs	Multilineage-inducible cells and uses thereof
JP4790592B2 (ja)	2003-02-11	2011-10-12	ダビース，ジヨン・イー	ヒト臍帯のウォートンジェリーからの前駆細胞
JP2006517975A (ja) *	2003-02-13	2006-08-03	アンスロジェネシスコーポレーション	疾患、障害または症状を患っている個体を治療するための臍帯血の使用
US8197837B2 (en)	2003-03-07	2012-06-12	Depuy Mitek, Inc.	Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
EP1620827B1 (en) *	2003-04-24	2010-06-02	Koninklijke Philips Electronics N.V.	Non-invasive left ventricular volume determination
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
ES2552226T3 (es)	2003-06-27	2015-11-26	DePuy Synthes Products, Inc.	Reparación y regeneración de cartílago y hueso utilizando células derivadas posparto
US9592258B2 (en)	2003-06-27	2017-03-14	DePuy Synthes Products, Inc.	Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US8491883B2 (en) *	2003-06-27	2013-07-23	Advanced Technologies And Regenerative Medicine, Llc	Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US20060223177A1 (en)	2003-06-27	2006-10-05	Ethicon Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US8518390B2 (en)	2003-06-27	2013-08-27	Advanced Technologies And Regenerative Medicine, Llc	Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US8226715B2 (en)	2003-06-30	2012-07-24	Depuy Mitek, Inc.	Scaffold for connective tissue repair
US10583220B2 (en)	2003-08-11	2020-03-10	DePuy Synthes Products, Inc.	Method and apparatus for resurfacing an articular surface
DK1653994T3 (da) *	2003-08-12	2010-03-15	Tigenix Nv	Anvendelse af CXCL6 chemokin i forebyggelsen eller gendannelse af bruskdefekter
US8043614B2 (en)	2004-03-09	2011-10-25	Ahlfors Jan-Eric W	Autogenic living scaffolds and living tissue matrices: methods and uses thereof
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
US7316822B2 (en) *	2003-11-26	2008-01-08	Ethicon, Inc.	Conformable tissue repair implant capable of injection delivery
US7682828B2 (en)	2003-11-26	2010-03-23	Whitehead Institute For Biomedical Research	Methods for reprogramming somatic cells
EP1694328A4 (en) *	2003-12-02	2010-02-17	Celgene Corp	METHOD AND COMPOSITIONS FOR THE TREATMENT AND SUPPLY OF HEMOGLOBINOPATHY AND ANEMIA
US7901461B2 (en) *	2003-12-05	2011-03-08	Ethicon, Inc.	Viable tissue repair implants and methods of use
JP2005168360A (ja) *	2003-12-09	2005-06-30	Olympus Corp	生体組織補填体の検査方法、装置、細胞培養容器および培養状態検査方法
US20050176139A1 (en) *	2004-01-12	2005-08-11	Yao-Chang Chen	Placental stem cell and methods thereof
WO2005071066A1 (en) *	2004-01-23	2005-08-04	Board Of Regents, The University Of Texas System	Methods and compositions for preparing pancreatic insulin secreting cells
US11395865B2 (en)	2004-02-09	2022-07-26	DePuy Synthes Products, Inc.	Scaffolds with viable tissue
WO2005093044A1 (en)	2004-03-22	2005-10-06	Osiris Therapeutics, Inc.	Mesenchymal stem cells and uses therefor
US8137686B2 (en)	2004-04-20	2012-03-20	Depuy Mitek, Inc.	Nonwoven tissue scaffold
US8221780B2 (en) *	2004-04-20	2012-07-17	Depuy Mitek, Inc.	Nonwoven tissue scaffold
US7622108B2 (en) *	2004-04-23	2009-11-24	Bioe, Inc.	Multi-lineage progenitor cells
CA2563518C (en) *	2004-04-23	2014-09-02	Bioe, Inc.	Multi-lineage progenitor cells
US8765119B2 (en) *	2004-05-06	2014-07-01	University Of South Florida	Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells
US20060083732A1 (en) *	2004-06-30	2006-04-20	Arlene Gwon	Hyaluronic acid in the enhancement of lens regeneration
US7794697B2 (en)	2004-06-30	2010-09-14	Abbott Medical Optics Inc.	Enhancement of lens regeneration using materials comprising polysiloxane polymers
US8802651B2 (en) *	2004-06-30	2014-08-12	Abbott Medical Optics Inc.	Hyaluronic acid in the enhancement of lens regeneration
AU2005273077B2 (en)	2004-08-16	2011-02-24	Cellresearch Corporation Pte Ltd	Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
US20060045872A1 (en)	2004-08-25	2006-03-02	Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco	Use of adipose tissue-derived stromal stem cells in treating fistula
US20060069008A1 (en) *	2004-09-28	2006-03-30	Sanjay Mistry	Treatment of neurological deficits in the striatum or substanta nigra pars compacta
US8039258B2 (en) *	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US20080038316A1 (en) *	2004-10-01	2008-02-14	Wong Vernon G	Conveniently implantable sustained release drug compositions
US7473678B2 (en)	2004-10-14	2009-01-06	Biomimetic Therapeutics, Inc.	Platelet-derived growth factor compositions and methods of use thereof
US7842304B2 (en) *	2004-10-29	2010-11-30	Nexeon Medsystems, Inc.	Methods and apparatus for treating an injured nerve pathway
US11660317B2 (en)	2004-11-08	2023-05-30	The Johns Hopkins University	Compositions comprising cardiosphere-derived cells for use in cell therapy
US8017395B2 (en) *	2004-12-17	2011-09-13	Lifescan, Inc.	Seeding cells on porous supports
US20060166361A1 (en) *	2004-12-21	2006-07-27	Agnieszka Seyda	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
WO2006101548A2 (en) *	2004-12-21	2006-09-28	Ethicon, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060153815A1 (en) *	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
EP1831355A2 (en) *	2004-12-23	2007-09-12	Ethicon, Inc.	Soft tissue repair and regeneration using postpartum-derived cells and cell products
WO2006071773A2 (en) *	2004-12-23	2006-07-06	Ethicon Incoporated	Treatment of osteochondral diseases using postpartum-derived cells and products thereof
CA2592435C (en)	2004-12-23	2017-03-28	DePuy Synthes Products, Inc.	Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
US20060182724A1 (en) *	2005-02-15	2006-08-17	Riordan Neil H	Method for expansion of stem cells
JP4783909B2 (ja) *	2005-03-04	2011-09-28	国立大学法人京都大学	心臓組織由来の多能性幹細胞
CN103361302A (zh)	2005-03-31	2013-10-23	斯丹姆涅恩有限公司	从高度纯化来自羊膜的细胞群获得的细胞裂解产物的组合物
US20060222634A1 (en)	2005-03-31	2006-10-05	Clarke Diana L	Amnion-derived cell compositions, methods of making and uses thereof
US8153430B2 (en) *	2005-03-31	2012-04-10	Stemnion, Inc.	Methods related to surgery
US8999706B2 (en) *	2005-04-12	2015-04-07	The Trustees Of The University Of Pennsylvania	Methods for preparation of human hair-follicle derived multipotent adult stem cells
WO2006113731A2 (en) *	2005-04-20	2006-10-26	University Of Florida Research Foundation, Inc.	Bone marrow-derived neurogenic cells and uses thereof
US20100087546A1 (en) *	2005-04-20	2010-04-08	Biogenic Innovations, Llc	Use of dimethyl sulfone (msm) to reduce homocysteine levels
KR20080007380A (ko) *	2005-04-25	2008-01-18	메사추세츠 인스티튜트 오브 테크놀로지	지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및방법
AU2006202209B2 (en) *	2005-05-27	2011-04-14	Lifescan, Inc.	Amniotic fluid derived cells
CN101484575B (zh) *	2005-06-08	2013-10-02	森托科尔公司	用于眼变性的细胞疗法
GB0511723D0 (en) *	2005-06-09	2005-07-13	Smith & Nephew	Placental stem cells
WO2006135899A2 (en) *	2005-06-13	2006-12-21	The Johns Hopkins University	Survival, differentiation and structural intergration of human neural stem cells grafted into the adult spinal cord
RU2284190C1 (ru) *	2005-06-14	2006-09-27	Дмитрий Дмитриевич Генкин	Способ лечения ишемической болезни сердца, или инфаркта миокарда и его последствий, или ишемии мозга, вызванной атеросклерозом или острым нарушением мозгового кровообращения, и ее последствий, или ишемии нижних конечностей, вызванной атеросклерозом
US7838503B2 (en) *	2005-06-15	2010-11-23	Children's Medical Center Corporation	Methods for extending the replicative lifespan of cells
US20140336514A1 (en) *	2005-08-05	2014-11-13	Gholam A. Peyman	Methods to regulate polarization and enhance function of cells
US20150119794A1 (en) *	2005-08-05	2015-04-30	Gholam A. Peyman	Methods to regulate polarization and enhance function of cells
WO2007033180A1 (en)	2005-09-12	2007-03-22	Abela Pharmaceuticals, Inc.	Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US8480797B2 (en)	2005-09-12	2013-07-09	Abela Pharmaceuticals, Inc.	Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
EP2324838A1 (en)	2005-09-12	2011-05-25	Abela Pharmaceuticals, Inc.	Compositions Comprising Dimethyl Sulfoxide (DMSO)
WO2007033083A2 (en)	2005-09-12	2007-03-22	Abela Pharmaceuticals, Inc.	Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
JP2007106760A (ja) *	2005-09-16	2007-04-26	Kenji Yoshida	造血幹細胞増殖剤
MX342474B (es)	2005-09-23	2016-09-30	Cellerix Sl	Poblaciones celulares con actividad inmunoreguladora, método de aislamiento y usos.
CA2999420A1 (en)	2005-09-27	2007-04-05	Tissuetech, Inc.	Amniotic membrane preparations and purified compositions and methods of use
AU2006304277B2 (en)	2005-10-13	2012-07-05	Celularity Inc.	Immunomodulation using placental stem cells
AU2006304274B2 (en) *	2005-10-13	2012-08-16	Celularity Inc.	Production of oligodendrocytes from placenta-derived stem cells
JP4921767B2 (ja) *	2005-10-14	2012-04-25	株式会社カネカ	細胞の分化誘導方法
US10117900B2 (en) *	2005-11-09	2018-11-06	Athersys, Inc.	MAPC treatment of brain injuries and diseases
WO2007056560A2 (en) *	2005-11-09	2007-05-18	Chemimage Corporation	System and method for cytological analysis by raman spectroscopic imaging
US11000546B2 (en)	2005-11-09	2021-05-11	Athersys, Inc.	Immunomodulatory properties of MAPCs and uses thereof
WO2007059084A2 (en) *	2005-11-14	2007-05-24	The New England Medical Center Hospitals, Inc.	Methods for preparing cord matrix stem cells (cmsc) for long term storage and for preparing a segment of umbilical cord for cryopreservation
KR20080084808A (ko) *	2005-11-17	2008-09-19	바이오미메틱 세라퓨틱스, 인크.	ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
JP5289970B2 (ja) *	2005-12-16	2013-09-11	エシコン・インコーポレイテッド	組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
AU2006327073B2 (en) *	2005-12-19	2012-08-30	Ethicon, Inc.	In vitro expansion of postpartum derived cells in roller bottles
CA2634820C (en) *	2005-12-22	2021-05-25	Jane Ennis	Viable cells from frozen umbilical cord tissue
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
CN105106239A (zh) *	2005-12-28	2015-12-02	伊西康公司	使用产后衍生细胞治疗外周血管疾病
EP1979050B1 (en) *	2005-12-28	2017-04-19	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using postpartum-derived cells
EP1974013A2 (en) *	2005-12-29	2008-10-01	Anthrogenesis Corporation	Improved composition for collecting and preserving placental stem cells and methods of using the composition
US8455250B2 (en)	2005-12-29	2013-06-04	Anthrogenesis Corporation	Co-culture of placental stem cells and stem cells from a second source
ES2671355T3 (es)	2005-12-29	2018-06-06	Anthrogenesis Corporation	Poblaciones de células madre placentarias
EP1981970A4 (en)	2006-01-11	2009-10-21	Technion Res & Dev Foundation	TISSUE CONSTRUCTION TISSUE TREATMENT DERIVED FROM A HUMAN EMBRYONIC STEM CELL
US20080286249A1 (en) *	2006-01-12	2008-11-20	Varney Timothy R	Use of mesenchymal stem cells for treating genetic diseases and disorders
US20070253931A1 (en) *	2006-01-12	2007-11-01	Osiris Therapeutics, Inc.	Use of mesenchymal stem cells for treating genetic diseases and disorders
US8871198B2 (en) *	2006-03-29	2014-10-28	Stemnion, Inc.	Methods related to wound healing
US9944900B2 (en) *	2006-01-18	2018-04-17	Hemacell Perfusion	Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
GB0600972D0 (en) *	2006-01-18	2006-03-01	Univ Leeds	Enrichment of cells
US7875451B2 (en) *	2006-01-19	2011-01-25	The University Of Washington	Formulation to improve survival of transplanted cells
CN103655618A (zh)	2006-01-23	2014-03-26	阿特西斯公司	无附加的免疫抑制治疗的mapc治疗法
CA2640185A1 (en) *	2006-01-24	2007-08-02	Christopher J. Centeno	Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting
FR2896511B1 (fr) *	2006-01-26	2012-10-26	Centre Nat Rech Scient	Procede de culture de cellules issues du tissu adipeux et leurs applications.
ES2427993T3 (es)	2006-02-09	2013-11-05	Biomimetic Therapeutics, Llc	Composiciones y métodos para el tratamiento de hueso
US20090232777A1 (en) *	2006-03-01	2009-09-17	Evy Lundgren-Akerlund	Expansion and Differentiation of Mesenchymal Stem Cells
WO2007099534A2 (en) *	2006-03-01	2007-09-07	The Regenerative Medicine Institute	Compostions and populations of cells obtained from the umbilical cord and methods of producing the same
ES2549528T3 (es) *	2006-03-23	2015-10-29	Pluristem Ltd.	Métodos de expansión de células y usos de células y de medios de acondicionamiento producidos por los mismos para terapia
US20110171182A1 (en) *	2006-03-23	2011-07-14	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
US7727763B2 (en) *	2006-04-17	2010-06-01	Bioe, Llc	Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
US20090208466A1 (en) *	2006-04-21	2009-08-20	James Yoo	Ink-jet printing of tissues
US9456979B2 (en) *	2006-04-27	2016-10-04	Sri International	Adminstration of intact mammalian cells to the brain by the intranasal route
US8741643B2 (en)	2006-04-28	2014-06-03	Lifescan, Inc.	Differentiation of pluripotent stem cells to definitive endoderm lineage
EP2029149B1 (en)	2006-05-05	2017-04-19	John E. Davies	Immune privileged and modulatory progenitor cells
EP4094578A1 (en)	2006-05-11	2022-11-30	Celularity Inc.	Methods for collecting and using placenta cord blood stem cells
US20080050814A1 (en) *	2006-06-05	2008-02-28	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
WO2007146105A2 (en) *	2006-06-05	2007-12-21	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
WO2007146123A2 (en) *	2006-06-09	2007-12-21	Anthrogenesis Corporation	Placental niche and use thereof to culture stem cells
US8475788B2 (en)	2006-06-14	2013-07-02	Stemnion, Inc.	Methods of treating spinal cord injury and minimizing scarring
EP2035093A4 (en) *	2006-06-14	2010-02-17	Stemnion Inc	METHODS FOR TREATING SPINAL CORD INJURY AND MINIMIZING THE SCALING SCALE
US20070292401A1 (en) *	2006-06-20	2007-12-20	Harmon Alexander M	Soft tissue repair and regeneration using stem cell products
CN101627112A (zh) *	2006-06-28	2010-01-13	堪萨斯大学	将来自脐带基质的干细胞分化为肝细胞谱系细胞
US9161967B2 (en)	2006-06-30	2015-10-20	Biomimetic Therapeutics, Llc	Compositions and methods for treating the vertebral column
US9642891B2 (en) *	2006-06-30	2017-05-09	Biomimetic Therapeutics, Llc	Compositions and methods for treating rotator cuff injuries
EP2484308A1 (en) *	2006-07-24	2012-08-08	International Stem Cell Corporation	Synthetic cornea from retinal stem cells
US7993918B2 (en) *	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
US8822030B2 (en)	2006-08-11	2014-09-02	Aqua Resources Corporation	Nanoplatelet metal hydroxides and methods of preparing same
WO2008021256A2 (en) *	2006-08-11	2008-02-21	Aqua Resources Corporation	Nanoplatelet metal hydroxides and methods of preparing same
US7671014B2 (en) *	2006-08-14	2010-03-02	Warsaw Orthopedic, Inc.	Flowable carrier matrix and methods for delivering to a patient
US8372437B2 (en)	2006-08-17	2013-02-12	Mimedx Group, Inc.	Placental tissue grafts
US20100178274A1 (en) *	2006-08-22	2010-07-15	Ichiro Sekiya	Application of synovium-derived mesenchymal stem cells (mscs) for cartilage or meniscus regeneration
US20080082170A1 (en) *	2006-09-29	2008-04-03	Peterman Marc M	Apparatus and methods for surgical repair
US20080078411A1 (en) *	2006-10-03	2008-04-03	Restore Medical, Inc.	Tongue implant for sleep apnea
US20080078412A1 (en) *	2006-10-03	2008-04-03	Restore Medical, Inc.	Tongue implant
DK2078073T3 (da)	2006-10-12	2013-10-28	Ethicon Inc	Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering
EP1913869A3 (en) *	2006-10-19	2008-12-10	Esaote S.p.A.	Diagnostic imaging method and apparatus for the anatomical region of the pelvic floor
ZA200902233B (en) *	2006-10-23	2010-07-28	Anthrogenesis Corp	Methods and compositions for treatment of bone defects with placental cell populations
WO2008073628A2 (en) *	2006-11-03	2008-06-19	Biomimetic Therapeutics, Inc.	Compositions and methods for arthrodetic procedures
EP2089511B1 (en) *	2006-11-13	2014-09-17	DePuy Synthes Products, LLC	In vitro expansion of postpartum-derived cells using microcarriers
US20080132803A1 (en) *	2006-11-30	2008-06-05	Hyman Friedlander	Method and system for doing business by mining the placental-chord complex
WO2008073331A2 (en) *	2006-12-07	2008-06-19	Teva Pharmaceutical Industries Ltd.	Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
WO2008082525A1 (en) *	2006-12-19	2008-07-10	National Stem Cell Inc	Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
US20100303770A1 (en) *	2006-12-28	2010-12-02	John Maslowski	Methods for culturing dermal cells for treatment of skin injuries such as burns
US7980000B2 (en)	2006-12-29	2011-07-19	Applied Materials, Inc.	Vapor dryer having hydrophilic end effector
ES2623141T3 (es) *	2007-01-17	2017-07-10	Noveome Biotherapeutics, Inc.	Nuevos métodos para modular respuestas inflamatorias y/o inmunitarias
SI2120977T1 (sl) *	2007-02-12	2014-01-31	Anthrogenesis Coroporation	Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic
EP2129775A1 (en) *	2007-02-12	2009-12-09	Anthrogenesis Corporation	Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
CA2678875A1 (en) *	2007-02-20	2008-08-28	Biomimetic Therapeutics, Inc.	Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw
CN102851254A (zh) *	2007-03-01	2013-01-02	干细胞国际公司	制备、分离及超低温保存子宫内膜/月经细胞
WO2008109816A1 (en) *	2007-03-08	2008-09-12	Hemacell Perfusion, Inc.	Method for isolation of afterbirth derived cells
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
EP2626416A3 (en) *	2007-04-07	2013-12-18	The Whitehead Institute for Biomedical Research	Reprogramming of somatic cells
EP2139497B1 (en) *	2007-04-13	2013-11-06	Stemnion, INC.	Methods for treating nervous system injury and disease
CN101668848B (zh)	2007-04-26	2014-10-22	雷蒙特亚特特拉维夫大学有限公司	来自口腔粘膜的多能自体干细胞和使用方法
WO2008137115A1 (en)	2007-05-03	2008-11-13	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8574567B2 (en)	2007-05-03	2013-11-05	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8114668B2 (en) *	2007-05-14	2012-02-14	Cardiac Pacemakers, Inc.	Composition for cold storage of stem cells
KR20150041157A (ko)	2007-05-21	2015-04-15	웨이크 포리스트 유니버시티 헬스 사이언시즈	소변으로부터의 전구 세포 및 이를 사용하는 방법
TWM322542U (en) *	2007-05-23	2007-11-21	Universal Scient Ind Co Ltd	Testing machine
US20090053182A1 (en) *	2007-05-25	2009-02-26	Medistem Laboratories, Inc.	Endometrial stem cells and methods of making and using same
DE602007010434D1 (de) *	2007-06-01	2010-12-23	Allergan Inc	Gerät zur Erzeugung des zugspannungsinduzierten Wachstums von biologischem Gewebe
US9693486B1 (en) *	2007-06-14	2017-06-27	Switch, Ltd.	Air handling unit with a canopy thereover for use with a data center and method of using the same
US8273526B2 (en)	2007-06-18	2012-09-25	Children's Hospital & Research Center At Oakland	Method of isolating stem and progenitor cells from placenta
US20090004253A1 (en) *	2007-06-29	2009-01-01	Brown Laura J	Composite device for the repair or regeneration of tissue
US20090004271A1 (en)	2007-06-29	2009-01-01	Brown Laura J	Morselized foam for wound treatment
US9080145B2 (en)	2007-07-01	2015-07-14	Lifescan Corporation	Single pluripotent stem cell culture
US9095562B2 (en)	2007-07-05	2015-08-04	Regenerative Sciences, Inc.	Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
DE102007034679A1 (de) *	2007-07-25	2009-01-29	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Materialzusammensetzungen, welche aus exokrinem Drüsengewebe erhaltene adulte Stammzellen enthalten, insbesondere zur Verwendung in der Regenerationsmedizin, z.B. zur Wiederherstellung von verletztem oder geschädigtem Myokardgewebe
US20090024224A1 (en)	2007-07-16	2009-01-22	Chen Silvia S	Implantation of cartilage
EP2192908A4 (en) *	2007-07-25	2010-09-01	Bioe Inc	DIFFERENTIATION OF PRECURSOR CELLS OF MULTIPLE ABSTRACTS AGAINST CHONDROCYTES
EP2520309A1 (en)	2007-07-27	2012-11-07	Humacyte, Inc.	Compositions and methods for soft tissue augmentation
KR101617243B1 (ko)	2007-07-31	2016-05-02	라이프스캔, 인코포레이티드	인간 배아 줄기 세포의 분화
AU2008284277B2 (en) *	2007-08-08	2011-04-28	Shire Regenerative Medicine, Inc.	Materials and methods for treating skeletal system damage and promoting skeletal system repair and regeneration
US20090062907A1 (en) *	2007-08-31	2009-03-05	Quijano Rodolfo C	Self-expanding valve for the venous system
US20090068153A1 (en) *	2007-09-06	2009-03-12	Vitelli Francesca P	Cell composition for tissue regeneration
EP2197270B8 (en)	2007-09-07	2020-03-04	Surgical Biologics, LLC	Placental tissue grafts and improved methods of preparing and using the same
KR20140107677A (ko)	2007-09-19	2014-09-04	플루리스템 리미티드	지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도
US20090136553A1 (en) *	2007-09-25	2009-05-28	Gerlach Jorg C	Triggerably dissolvable hollow fibers for controlled delivery
KR20220122774A (ko) *	2007-09-26	2022-09-02	셀룰래리티 인코포레이티드	인간 태반 관류액으로부터의 혈관형성 세포
RS53841B1 (sr)	2007-09-28	2015-06-30	Anthrogenesis Corporation	Supresija tumora korišćenjem humanog placentalnog perfuzata i intermedijernih ćelija ubica poreklom iz humane placente
CA2701435C (en) *	2007-10-05	2017-06-20	Ethicon, Inc.	Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
WO2009052209A2 (en) *	2007-10-16	2009-04-23	University Of Kansas	Isolation of stem cells and effective control of contamination
US20100297234A1 (en) *	2007-10-19	2010-11-25	Ilene Sugino	Method of using an extracellular matrix to enhance cell transplant survival and differentiation
US20120219737A1 (en)	2007-10-19	2012-08-30	University Of Medicine And Dentistry Of New Jersey	Production of extracellular matrix, conditioned media and uses thereof
DK2217329T3 (en) *	2007-11-07	2018-04-23	Anthrogenesis Corp	APPLICATION OF NAVLINE BLOOD IN THE TREATMENT OF COMPLIANCES IN CONNECTION WITH PREGNANCY BIRTH
WO2009064958A1 (en) *	2007-11-14	2009-05-22	Osteosphere, Llc	Ex-vivo production of human demineralized bone matrix
CA3123528C (en)	2007-11-27	2026-01-13	Lifescan, Inc.	Differentiation of human embryonic stem cells to pancreatic cells
US20090163990A1 (en) *	2007-12-19	2009-06-25	Chunlin Yang	Decellularized omentum matrix and uses thereof
US20110200642A1 (en) *	2007-12-19	2011-08-18	Regenerative Sciences, Llc	Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
US8236538B2 (en)	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
WO2009085216A2 (en)	2007-12-20	2009-07-09	Squicor	Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease
ES2621610T3 (es) *	2007-12-27	2017-07-04	DePuy Synthes Products, Inc.	Tratamiento de la degeneración de discos intervertebrales utilizando células derivadas de tejido cordón umbilical humano
US20100279413A1 (en) *	2008-01-14	2010-11-04	Zymes, Llc	Applications of ubiquinones and ubiquinols
US8088163B1 (en)	2008-02-06	2012-01-03	Kleiner Jeffrey B	Tools and methods for spinal fusion
AU2009212151C1 (en)	2008-02-07	2015-09-17	Stryker Corporation	Compositions and methods for distraction osteogenesis
EP2254608B1 (en) *	2008-02-07	2016-05-04	Shahar Cohen	Compartmental extract compositions for tissue engineering
US20090209456A1 (en) *	2008-02-19	2009-08-20	Iliana Sweis	Compositions and methods for improving facial and body aesthetics
BR122017025207B1 (pt)	2008-02-21	2021-03-16	Centocor Ortho Biotech Inc	superfície que faz parte de um recipiente ou matriz destinada para uso em uma cultura de células ou análises, desprovida de uma camada de células alimentadoras e desprovida de uma camada adsorvente
US8318485B2 (en) *	2008-02-25	2012-11-27	Natalie Gavrilova	Stem cell therapy for the treatment of diabetic retinopathy and diabetic optic neuropathy
US20090220995A1 (en) *	2008-02-28	2009-09-03	Sachs David H	Multiple administrations of umbilicus derived cells
US20090232782A1 (en) *	2008-03-14	2009-09-17	Yu-Show Fu	Method for treating brain ischemic injury through transplantation of human umbilical mesenchymal stem cells
US20110052533A1 (en) *	2008-03-14	2011-03-03	Regenerative Sciences, Llc	Compositions and Methods for Cartilage Repair
AU2009240738B2 (en)	2008-04-21	2014-09-11	Tissue Regeneration Therapeutics, Inc.	Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
US8623648B2 (en)	2008-04-24	2014-01-07	Janssen Biotech, Inc.	Treatment of pluripotent cells
US9358320B2 (en)	2008-04-25	2016-06-07	Allosource	Multi-layer tissue patches
US9480549B2 (en)	2008-04-25	2016-11-01	Allosource	Multi-layer tissue patches
WO2009134991A2 (en)	2008-04-30	2009-11-05	Ethicon, Inc.	Tissue engineered blood vessel
US20110143429A1 (en) *	2008-04-30	2011-06-16	Iksoo Chun	Tissue engineered blood vessels
CA2724839A1 (en) *	2008-05-21	2009-11-26	Bioe Llc	Differentiation of multi-lineage progenitor cells to pancreatic cells
US20210378834A1 (en)	2008-05-22	2021-12-09	Spinal Surgical Strategies, Inc., A Nevada Corporation D/B/A Kleiner Device Labs	Spinal fusion cage system with inserter
WO2010011407A2 (en) *	2008-05-23	2010-01-28	President And Fellows Of Harvard College	Methods of generating patterned soft substrates and uses thereof
US20090297485A1 (en) *	2008-05-28	2009-12-03	Allan Mishra	Compositions and methods for treating psychiatric and neurodegenerative disorders
CA2727625A1 (en) *	2008-06-11	2009-12-17	The Children's Mercy Hospital	Composition comprising decellularized tissue
AU2009257219B2 (en)	2008-06-13	2015-01-29	Whitehead Institute For Biomedical Research	Programming and reprogramming of cells
MX2010014304A (es) *	2008-06-26	2011-02-15	Kci Licensing Inc	Estimulacion de la formacion de cartilago utilizando el tratamiento de presion reducida.
WO2009157559A1 (ja) *	2008-06-27	2009-12-30	独立行政法人産業技術総合研究所	膵臓疾患又は糖尿病のための膵臓細胞再生移植用キット
EP2318516A1 (en) *	2008-06-30	2011-05-11	Centocor Ortho Biotech Inc.	Differentiation of pluripotent stem cells
US20100015711A1 (en)	2008-06-30	2010-01-21	Janet Davis	Differentiation of Pluripotent Stem Cells
US20100028307A1 (en) *	2008-07-31	2010-02-04	O'neil John J	Pluripotent stem cell differentiation
DK2330889T3 (en)	2008-08-20	2017-01-30	Anthrogenesis Corp	Improved cell composition and process for making the same
KR20180108887A (ko) *	2008-08-20	2018-10-04	안트로제네시스 코포레이션	단리된 태반 세포를 사용한 뇌졸중 치료
MX2011001992A (es) *	2008-08-22	2011-03-29	Anthrogenesis Corp	Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias.
MX2011002328A (es)	2008-09-02	2011-05-19	Pluristem Ltd	Celulas adherentes del tejido de placenta y su uso en terapia.
MX2011002555A (es)	2008-09-09	2011-08-03	Biomimetic Therapeutics Inc	Composiciones de factor de crecimiento derivadas de plaquetas y metodo para el tratamiento de lesiones de tendon y ligamentos.
US9446227B2 (en)	2008-09-12	2016-09-20	Sonescence, Inc.	Ultrasonic dispersion of compositions in tissue
US20100069827A1 (en) *	2008-09-12	2010-03-18	Barry Neil Silberg	Pre-Surgical Prophylactic Administration of Antibiotics and Therapeutic Agents
ES2694000T3 (es)	2008-10-06	2018-12-17	3-D Matrix Ltd.	Tapón de tejido
WO2010048418A1 (en) *	2008-10-22	2010-04-29	The Trustees Of Columbia University In The City Of New York	Cartilage regeneration without cell transplantation
CA2742267C (en)	2008-10-31	2019-06-04	Centocor Ortho Biotech Inc.	Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
US20100119492A1 (en)	2008-10-31	2010-05-13	Synthes Usa, Llc	Method and device for activating stem cells
BRPI0919885A2 (pt) *	2008-10-31	2015-08-11	Centocor Ortho Biotech Inc	Diferenciação de células-tronco embrionárias humanas para a linhagem endócrina pancreática
BRPI0921494A2 (pt)	2008-11-03	2018-10-30	Prad Reasearch And Development Ltd	método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
CA2743566C (en) *	2008-11-19	2021-11-09	Anthrogenesis Corporation	Amnion derived adherent cells
AU2009316583B2 (en) *	2008-11-20	2016-04-21	Janssen Biotech, Inc.	Methods and compositions for cell attachment and cultivation on planar substrates
US20100124781A1 (en)	2008-11-20	2010-05-20	Shelley Nelson	Pluripotent Stem Cell Culture on Micro-Carriers
RU2011116449A (ru) *	2008-11-20	2012-12-27	Лайфселл Корпорейшн	Способ лечения и предотвращения парастомальных грыж
NZ602569A (en) *	2008-11-21	2014-03-28	Anthrogenesis Corp	Treatment of diseases, disorders or conditions of the lung using placental cells
US8366748B2 (en)	2008-12-05	2013-02-05	Kleiner Jeffrey	Apparatus and method of spinal implant and fusion
WO2010065239A1 (en) *	2008-12-05	2010-06-10	Wake Forest University Health Sciences	Stem cells from urine and methods for using the same
WO2010064702A1 (ja) *	2008-12-05	2010-06-10	国立大学法人東京大学	癌の予後を予測するためのバイオマーカー
JP2012510874A (ja)	2008-12-05	2012-05-17	リジェネレイティブサイエンシーズ，エルエルシー	無血管組織の修復を促進するための方法及び組成物
US20100168022A1 (en) *	2008-12-11	2010-07-01	Centeno Christopher J	Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
JP5646502B2 (ja) *	2008-12-19	2014-12-24	デピュイ・シンセス・プロダクツ・エルエルシーＤｅＰｕｙＳｙｎｔｈｅｓＰｒｏｄｕｃｔｓ，ＬＬＣ	神経因性疼痛を治療するための臍帯組織由来細胞
AU2009327383B2 (en) *	2008-12-19	2014-08-28	DePuy Synthes Products, LLC	Regeneration and repair of neural tissue following injury
US10179900B2 (en) *	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
CN107028983A (zh) *	2008-12-19	2017-08-11	德普伊新特斯产品有限责任公司	肺部疾病和病症的治疗
US20130302283A1 (en) *	2012-05-14	2013-11-14	Advanced Technologies And Regenerative Medicine, Llc	hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
US8771677B2 (en) *	2008-12-29	2014-07-08	Vladimir B Serikov	Colony-forming unit cell of human chorion and method to obtain and use thereof
KR20110107357A (ko) *	2008-12-30	2011-09-30	케이씨아이 라이센싱 인코포레이티드	연골 회복을 위한 미세골절 수술의 감압 증대
JP5701614B2 (ja) *	2009-01-23	2015-04-15	国立大学法人東京大学	培養細胞の評価方法
US9247943B1 (en)	2009-02-06	2016-02-02	Kleiner Intellectual Property, Llc	Devices and methods for preparing an intervertebral workspace
WO2010093468A1 (en) *	2009-02-12	2010-08-19	University Of Southern California	Bioadhesive patch for sutureless closure of soft tissue
KR101422690B1 (ko) *	2009-02-27	2014-07-23	(주)차바이오앤디오스텍	배아줄기세포 유래 혈관형성전구세포의 배양 분비물을 포함하는 피부재생용 조성물 및 이의 용도
US8722034B2 (en) *	2009-03-26	2014-05-13	Depuy Synthes Products Llc	hUTC as therapy for Alzheimer's disease
CN102439136A (zh) *	2009-03-26	2012-05-02	加州大学校董	产生用于疾病修饰的抑制性rna的间充质干细胞
WO2010118059A1 (en) *	2009-04-06	2010-10-14	Capricor, Inc.	Systems and methods for cardiac tissue repair
MX357440B (es) *	2009-05-13	2018-07-10	Medipost Co Ltd	Trombospondina 1 (tsp-1), trombospondina 2 (tsp-2), receptor de interleucina 17b (il-17br) y factor de crecimiento tipo factor de crecimiento epidermico de union a heparina (hb-egf) asociados con actividades de celulas madre y aplicaciones de los mismos.
CA2762212C (en) *	2009-05-20	2015-12-29	Humacyte, Inc.	Elastin for soft tissue augmentation
WO2010138782A1 (en) *	2009-05-28	2010-12-02	University Of Central Florida Research	In vitro production of oligodendrocytes from human umbilical cord stem cells
US20150335400A1 (en) *	2009-06-17	2015-11-26	The Trustees Of Columbia University In The City Of New York	Tooth scaffolds
US8647617B2 (en)	2009-07-13	2014-02-11	Stemnion, Inc.	Methods for modulating inflammatory and/or immune responses
CA2768644A1 (en)	2009-07-20	2011-01-27	Janssen Biotech, Inc.	Differentiation of human embryonic stem cells
BR112012001480A2 (pt)	2009-07-20	2015-09-01	Janssen Biotech Inc	Diferenciação de células-tronco embriônicas humanas
JP5819826B2 (ja) *	2009-07-20	2015-11-24	ヤンセンバイオテツク，インコーポレーテツド	ヒト胚性幹細胞の分化
AU2010276201B2 (en) *	2009-07-21	2013-10-17	Healios K.K.	Use of stem cells to reduce leukocyte extravasation
ES2360434B1 (es) *	2009-07-21	2012-04-12	Universitat Internacional De Catalunya	Celulas madre pluripotenciales obtenidas a partir de la pulpa dental.
WO2011022071A2 (en) *	2009-08-20	2011-02-24	The Regents Of The University Of California	Cardiac compositions
US20110054929A1 (en) *	2009-09-01	2011-03-03	Cell Solutions Colorado Llc	Stem Cell Marketplace
US8207651B2 (en)	2009-09-16	2012-06-26	Tyco Healthcare Group Lp	Low energy or minimum disturbance method for measuring frequency response functions of ultrasonic surgical devices in determining optimum operating point
USD723682S1 (en)	2013-05-03	2015-03-03	Spinal Surgical Strategies, Llc	Bone graft delivery tool
US8685031B2 (en)	2009-09-18	2014-04-01	Spinal Surgical Strategies, Llc	Bone graft delivery system
USD750249S1 (en)	2014-10-20	2016-02-23	Spinal Surgical Strategies, Llc	Expandable fusion cage
US8906028B2 (en)	2009-09-18	2014-12-09	Spinal Surgical Strategies, Llc	Bone graft delivery device and method of using the same
US20170238984A1 (en)	2009-09-18	2017-08-24	Spinal Surgical Strategies, Llc	Bone graft delivery device with positioning handle
US9060877B2 (en)	2009-09-18	2015-06-23	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US10973656B2 (en)	2009-09-18	2021-04-13	Spinal Surgical Strategies, Inc.	Bone graft delivery system and method for using same
US10245159B1 (en)	2009-09-18	2019-04-02	Spinal Surgical Strategies, Llc	Bone graft delivery system and method for using same
US9186193B2 (en)	2009-09-18	2015-11-17	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US9173694B2 (en)	2009-09-18	2015-11-03	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US9629729B2 (en)	2009-09-18	2017-04-25	Spinal Surgical Strategies, Llc	Biological delivery system with adaptable fusion cage interface
WO2011038133A2 (en) *	2009-09-23	2011-03-31	Davinci Biosciences Llc	Umbilical cord lining stem cells and methods and material for isolating and culturing same
CA2777663A1 (en)	2009-10-16	2011-04-21	University Of Medicine And Dentistry Of New Jersey	Method for treating chronic nerve tissue injury using a cell therapy strategy
ES2665006T3 (es) *	2009-10-29	2018-04-24	Janssen Biotech, Inc.	Células madre pluripotentes
US9839609B2 (en)	2009-10-30	2017-12-12	Abela Pharmaceuticals, Inc.	Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
US9113950B2 (en)	2009-11-04	2015-08-25	Regenerative Sciences, Llc	Therapeutic delivery device
US20130028978A1 (en) *	2009-11-10	2013-01-31	The Trustees Of Columbia University In The City Of New York	Compositions and methods for wound treatment
US20130129686A1 (en) *	2009-11-19	2013-05-23	Regents Of The University	Reducing Inflammation Using Cell Therapy
CA2784415C (en)	2009-12-23	2019-06-18	Jean Xu	Differentiation of human embryonic stem cells
US9133439B2 (en) *	2009-12-23	2015-09-15	Janssen Biotech, Inc.	Differentiation of human embryonic stem cells
WO2011094181A1 (en) *	2010-01-26	2011-08-04	Anthrogenesis Corporation	Treatment of bone-related cancers using placental stem cells
NZ601400A (en)	2010-01-26	2013-11-29	Stem Cells Spin S A	Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use
US20110212065A1 (en)	2010-02-18	2011-09-01	Timothy Jansen	Methods of manufacture of therapeutic products comprising vitalized placental dispersions
EP3769695A1 (en) *	2010-02-19	2021-01-27	LifeCell Corporation	Abdominal wall treatment devices
WO2011103598A1 (en)	2010-02-22	2011-08-25	Biomimetic Therapeutics, Inc.	Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
WO2011109279A2 (en)	2010-03-01	2011-09-09	Centocor Ortho Biotech Inc.	Methods for purifying cells derived from pluripotent stem cells
SI2556145T1 (sl)	2010-04-07	2017-01-31	Anthrogenesis Corporation	Angiogeneza z uporabo placentnih matičnih celic
AU2011237743A1 (en)	2010-04-08	2012-11-01	Anthrogenesis Corporation	Treatment of sarcoidosis using placental stem cells
US9845457B2 (en)	2010-04-30	2017-12-19	Cedars-Sinai Medical Center	Maintenance of genomic stability in cultured stem cells
US8529883B2 (en)	2010-05-07	2013-09-10	Fibrocell Technologies, Inc.	Dosage unit formulations of autologous dermal fibroblasts
US9752125B2 (en)	2010-05-12	2017-09-05	Janssen Biotech, Inc.	Differentiation of human embryonic stem cells
US9352003B1 (en)	2010-05-14	2016-05-31	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en)	2010-05-14	2014-11-11	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en)	2010-05-14	2018-11-20	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2011153236A1 (en) *	2010-06-03	2011-12-08	The Board Of Trustees Of The Leland Stanford Junior University	Purified compositions of cardiovascular progenitor cells
ES2879246T3 (es)	2010-07-02	2021-11-22	Univ North Carolina Chapel Hill	Andamios de biomatriz
AU2011279250B2 (en)	2010-07-12	2014-12-04	California Institute Of Technology	Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
CN107828727A (zh)	2010-07-13	2018-03-23	人类起源公司	产生自然杀伤细胞的方法、由此获得的细胞群体及其用途
US8825388B2 (en)	2010-07-13	2014-09-02	Qualcomm Incorporated	Indoor likelihood heatmap
EP2600913A4 (en) *	2010-08-03	2015-02-18	Agency Science Tech & Res	MICROFABRICATED SUPPORT STRUCTURES
JP2012031127A (ja) *	2010-08-03	2012-02-16	Nagoya Univ	臍帯由来間葉系幹細胞を含む組成物
IL207586A0 (en)	2010-08-12	2010-12-30	Omrix Biopharmaceuticals Ltd	A fibrin based therapeutic preparation and use thereof
WO2012021885A1 (en) *	2010-08-13	2012-02-16	The Trustees Of Columbia University In The City Of New York	Three-dimensional tissue engineering devices and uses thereof
CA2809300A1 (en)	2010-08-31	2012-03-08	Janssen Biotech, Inc.	Differentiation of human embryonic stem cells
CN108517310B (zh)	2010-08-31	2022-02-15	詹森生物科技公司	人胚胎干细胞的分化
PH12013500349A1 (en)	2010-08-31	2022-03-30	Janssen Biotech Inc	Differentiation of pluripotent stem cells
CN103180435A (zh) *	2010-08-31	2013-06-26	库克通用生物技术有限责任公司	用于治疗动物疾病的全身的同种异体干细胞疗法
WO2012048275A2 (en)	2010-10-08	2012-04-12	Caridianbct, Inc.	Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US8546338B2 (en)	2010-12-08	2013-10-01	Johnson & Johnson Consumer Companies, Inc.	Self-assembling hydrogels based on dicephalic peptide amphiphiles
US8574899B2 (en)	2010-12-22	2013-11-05	Vladimir B Serikov	Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
AR093183A1 (es)	2010-12-31	2015-05-27	Anthrogenesis Corp	Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
JP5388233B2 (ja) *	2011-01-19	2014-01-15	富士ソフト株式会社	再生軟骨の軟骨特性を評価する方法
US12093036B2 (en)	2011-01-21	2024-09-17	Teladoc Health, Inc.	Telerobotic system with a dual application screen presentation
US8945536B2 (en) *	2011-01-26	2015-02-03	The Chinese University Of Hong Kong	Stem cell sheet for tissue repair
EP2686419B1 (en)	2011-03-18	2016-11-16	MicroVascular Tissues, Inc.	Allogeneic microvascular tissue for soft tissue treatments
EP3260533B1 (en)	2011-03-22	2019-09-11	Pluristem Ltd.	Methods for treating radiation or chemical injury
WO2012149486A1 (en)	2011-04-28	2012-11-01	Tissuetech, Inc.	Methods of modulating bone remodeling
US9758395B2 (en)	2011-04-28	2017-09-12	Aquero Company, Llc	Lysine-based polymer coagulants for use in clarification of process waters
WO2012149468A2 (en)	2011-04-29	2012-11-01	University Of Southern California	Instruments and methods for the implantation of cell-seeded substrates
US8877489B2 (en)	2011-12-05	2014-11-04	California Institute Of Technology	Ultrathin parylene-C semipermeable membranes for biomedical applications
US8834928B1 (en)	2011-05-16	2014-09-16	Musculoskeletal Transplant Foundation	Tissue-derived tissugenic implants, and methods of fabricating and using same
AU2012262311B2 (en) *	2011-05-31	2016-04-28	Lifecell Corporation	Adipose tissue matrices
EP3443968A1 (en)	2011-06-01	2019-02-20	Celularity, Inc.	Treatment of pain using placental stem cells
ES2822301T3 (es)	2011-06-10	2021-04-30	Tissuetech Inc	Métodos de procesamiento de tejidos de soporte fetal
US20140189897A1 (en)	2011-06-21	2014-07-03	Mayo Foundation For Medical Education And Research	Transgenic animals capable of being induced to delete senescent cells
US9133438B2 (en)	2011-06-29	2015-09-15	Biorestorative Therapies, Inc.	Brown fat cell compositions and methods
US20130005829A1 (en)	2011-06-30	2013-01-03	Advanced Technologies And Regenerative Medicine, Llc.	Segmented, epsilon-Caprolactone-Rich, Poly(epsilon-Caprolactone-co-p-Dioxanone) Copolymers for Medical Applications and Devices Therefrom
WO2013010045A1 (en)	2011-07-12	2013-01-17	Biotime Inc.	Novel methods and formulations for orthopedic cell therapy
ES2661587T3 (es)	2011-08-10	2018-04-02	Depuy Synthes Products Llc	Tratamiento de enfermedad vascular periférica usando células derivadas de tejido del cordón umbilical
WO2013055476A1 (en)	2011-09-09	2013-04-18	Anthrogenesis Corporation	Treatment of amyotrophic lateral sclerosis using placental stem cells
US9248013B2 (en)	2011-12-05	2016-02-02	California Institute Of Technology	3-Dimensional parylene scaffold cage
WO2013090645A1 (en)	2011-12-13	2013-06-20	Buck Institute For Research On Aging	Methods for improving medical therapies
US9162011B2 (en)	2011-12-19	2015-10-20	Allosource	Flowable matrix compositions and methods
US20130157365A1 (en) *	2011-12-20	2013-06-20	Advanced Technologies And Regenerative Medicine, Llc	Induced pluripotent stem cells from human umbilical cord tissue-derived cells
AU2012355463C1 (en)	2011-12-20	2016-09-22	Lifecell Corporation	Sheet tissue products
WO2013096252A1 (en)	2011-12-20	2013-06-27	Lifecell Corporation	Flowable tissue products
KR102203056B1 (ko)	2011-12-22	2021-01-14	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화
JP6301263B2 (ja)	2011-12-23	2018-03-28	デピュイ・シンセス・プロダクツ・インコーポレイテッド	ヒト臍帯組織由来細胞の検出
SI3321355T1 (sl)	2011-12-30	2021-11-30	Amit Patel	Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe
DK2806907T3 (en)	2012-01-24	2019-02-18	Lifecell Corp	EXTENDED TISSUE MATRIX
US9575054B2 (en) *	2012-02-23	2017-02-21	Anthrogenesis Corporation	Identification of antitumor compounds using placenta
US8940294B2 (en)	2012-03-02	2015-01-27	Tissuetech, Inc.	Methods of isolating and culturing stem cells
KR20140131999A (ko)	2012-03-07	2014-11-14	얀센 바이오테크 인코포레이티드	만능 줄기 세포의 증폭 및 유지를 위한 한정 배지
US20150064137A1 (en)	2012-04-17	2015-03-05	Kythera Biopharmaceuticals, Inc.	Use of engineered viruses to specifically kill senescent cells
US9999637B2 (en)	2012-04-24	2018-06-19	Lifecell Corporation	Functionalized tissue matrices
US9884076B2 (en)	2012-06-05	2018-02-06	Capricor, Inc.	Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
KR102667288B1 (ko)	2012-06-08	2024-05-17	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 췌장 내분비 세포로의 분화
ES2706065T3 (es)	2012-07-06	2019-03-27	3 D Matrix Ltd	Proceso de llenado-acabado para soluciones de péptidos
JP6282270B2 (ja)	2012-07-09	2018-02-21	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	組み換えにより生成されたパエニバシラス・ポリミキサに由来する中性プロテアーゼ
US11090338B2 (en)	2012-07-13	2021-08-17	Lifecell Corporation	Methods for improved treatment of adipose tissue
US8960674B2 (en)	2012-07-27	2015-02-24	Bally Gaming, Inc.	Batch card shuffling apparatuses including multi-card storage compartments, and related methods
AU2013302799B2 (en)	2012-08-13	2018-03-01	Cedars-Sinai Medical Center	Exosomes and micro-ribonucleic acids for tissue regeneration
US9901080B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9901081B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse for determining the role of senescent cells in cancer
US9872937B2 (en)	2012-09-19	2018-01-23	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
US10596202B2 (en)	2012-09-19	2020-03-24	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
ES2710921T3 (es)	2012-09-19	2019-04-29	Microvascular Tissues Inc	Composiciones para tratar y prevenir lesión y enfermedad tisular
US11819522B2 (en)	2012-09-19	2023-11-21	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
CA2885327A1 (en)	2012-09-26	2014-04-03	Lifecell Corporation	Processed adipose tissue
KR101728808B1 (ko) *	2012-09-28	2017-04-20	한국생명공학연구원	아세카이니드 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
ITTO20120859A1 (it) *	2012-10-02	2014-04-03	Univ Degli Studi Torino	Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari
WO2014066649A1 (en) *	2012-10-26	2014-05-01	The Regents Of The University Of California	A strategy for engineering various 3d tissues, organoids and vasculature
US10279018B2 (en)	2012-12-03	2019-05-07	Unity Biotechnology, Inc.	Immunogenic compositions for inducing an immune response for elimination of senescent cells
US20140170748A1 (en)	2012-12-14	2014-06-19	DePuy Synthes Products, LLC	Nutrient Enriched Media for hUTC Growth
WO2014105546A1 (en)	2012-12-31	2014-07-03	Janssen Biotech, Inc.	Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators
RU2768963C2 (ru)	2012-12-31	2022-03-25	Янссен Байотек, Инк.	Культивация эмбриональных стволовых клеток человека в воздушно-жидкостной зоне взаимодействия с целью их дифференцировки в панкреатические эндокринные клетки
US10370644B2 (en)	2012-12-31	2019-08-06	Janssen Biotech, Inc.	Method for making human pluripotent suspension cultures and cells derived therefrom
WO2014106141A1 (en)	2012-12-31	2014-07-03	Janssen Biotech, Inc.	Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
EP2756754B1 (de)	2013-01-17	2017-01-04	Vita 34 Ag	Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
US20140212390A1 (en) *	2013-01-30	2014-07-31	NuTech Medical, Inc.	Placental Membrane Preparation and Methods of Making and Using Same
AU2014215458A1 (en)	2013-02-05	2015-08-13	Anthrogenesis Corporation	Natural killer cells from placenta
WO2014164815A2 (en)	2013-03-12	2014-10-09	Allergan, Inc.	Adipose tissue combinations, devices, and uses thereof
CA2899246C (en)	2013-03-13	2022-12-06	Allosource	Fascia fibrous compositions and methods for their use and manufacture
EP3882336A1 (en) *	2013-03-14	2021-09-22	Celularity Inc.	Enhanced placental stem cells and uses thereof
WO2014150784A1 (en)	2013-03-15	2014-09-25	Allosource	Cell repopulated collagen matrix for soft tissue repair and regeneration
RU2539750C2 (ru) *	2013-04-09	2015-01-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)	Способ оценки иммуносупрессивных свойств мезенхимальных стромальных клеток человека
US20140350516A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Mechanical syringe accessory
US11229789B2 (en)	2013-05-30	2022-01-25	Neurostim Oab, Inc.	Neuro activator with controller
JP2016523125A (ja)	2013-05-30	2016-08-08	グラハムエイチ．クリーシー	局所神経性刺激
US10058572B2 (en) *	2013-08-15	2018-08-28	The Regents Of The University Of California	Placenta-derived multipotent stem cells
US9248384B2 (en)	2013-10-02	2016-02-02	Allergan, Inc.	Fat processing system
CN105793411B (zh)	2013-11-16	2018-04-17	泰尔茂比司特公司	生物反应器中的细胞扩增
EP3076982B1 (en)	2013-12-06	2020-02-19	Allosource	Method of drying sheets of tissue
WO2015095380A1 (en) *	2013-12-17	2015-06-25	Kassab Ghassan S	Devices, systems and methods for tissue engineering of luminal grafts
US20190269675A1 (en)	2014-01-28	2019-09-05	Buck Institute for Research and Aging	Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents
US20170216286A1 (en)	2014-01-28	2017-08-03	Mayo Foundation For Medical Education And Research	Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid
EP3099380B1 (en)	2014-01-28	2021-08-11	Buck Institute for Research on Aging	Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
US10328058B2 (en)	2014-01-28	2019-06-25	Mayo Foundation For Medical Education And Research	Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
WO2016179043A1 (en) *	2015-05-01	2016-11-10	Dermtech, Inc.	Non-invasive skin collection system
EP4555981A3 (en)	2014-02-12	2025-08-06	Genentech, Inc.	Method and apparatus for suprachoroidal administration of therapeutic agent
BR112016020584A2 (pt)	2014-03-10	2017-10-03	3 D Matrix Ltd	Composições de peptídeo auto-organizável
JP6684719B2 (ja)	2014-03-10	2020-04-22	株式会社スリー・ディー・マトリックス	ペプチド組成物の滅菌および濾過
JP6783143B2 (ja)	2014-03-25	2020-11-11	テルモビーシーティー、インコーポレーテッド	培地の受動的補充
CA2948126A1 (en) *	2014-05-07	2015-11-12	Osiris Therapeutics, Inc.	Therapeutic placental compositions, methods of making and methods of use
EP3140417B1 (en)	2014-05-09	2021-04-21	Reelabs Private Limited	Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders
US10029048B2 (en)	2014-05-13	2018-07-24	Allergan, Inc.	High force injection devices
EP3954759A1 (en)	2014-05-16	2022-02-16	Janssen Biotech, Inc.	Use of small molecules to enhance mafa expression in pancreatic endocrine cells
TW201603818A (zh)	2014-06-03	2016-02-01	組織科技股份有限公司	組成物及方法
US9949874B2 (en)	2014-06-06	2018-04-24	Janssen Biotech, Inc.	Therapeutic agent delivery device with convergent lumen
US9925088B2 (en)	2014-06-06	2018-03-27	Janssen Biotech, Inc.	Sub-retinal tangential needle catheter guide and introducer
US20160000550A1 (en) *	2014-07-05	2016-01-07	Deborah Nagle	Methods for treating diseases of the colon
AU2015286462B2 (en) *	2014-07-11	2021-04-15	Lymphogenix Limited	Cardiac cell culture material
US10064752B2 (en)	2014-09-11	2018-09-04	Orbit Biomedical Limited	Motorized suprachoroidal injection of therapeutic agent
US10322028B2 (en)	2014-09-11	2019-06-18	Orbit Biomedical Limited	Method and apparatus for sensing position between layers of an eye
US10219936B2 (en)	2014-09-11	2019-03-05	Orbit Biomedical Limited	Therapeutic agent delivery device with advanceable cannula and needle
CN107075470A (zh)	2014-09-18	2017-08-18	北卡罗来纳大学	哺乳动物肺球体和肺球体细胞及其应用
US10258502B2 (en)	2014-09-18	2019-04-16	Orbit Biomedical Limited	Therapeutic agent delivery device
US9504905B2 (en)	2014-09-19	2016-11-29	Bally Gaming, Inc.	Card shuffling device and calibration method
KR101613478B1 (ko) *	2014-09-22	2016-04-19	(주)안트로젠	중간엽줄기세포-하이드로겔을 함유하는 조성물 및 이의 제조방법
US20160090569A1 (en)	2014-09-26	2016-03-31	Terumo Bct, Inc.	Scheduled Feed
WO2016054591A1 (en)	2014-10-03	2016-04-07	Cedars-Sinai Medical Center	Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
CA2962954A1 (en)	2014-10-14	2016-04-21	Samuel Lynch	Compositions for treating wounds
US20180280447A1 (en) *	2014-10-29	2018-10-04	Sungkwang Medical Foundation	Placenta-derived cells excreting c3 or c1r complement and composition containing same
EP3212247B1 (en) *	2014-10-31	2021-04-07	The Administrators of the Tulane Educational Fund	Surgical grafts for replacing the nipple and areola or damaged epidermis
RU2750695C2 (ru)	2014-11-07	2021-07-01	Экзостемтех Ко., Лтд.	Композиция, включающая экзосому, полученную из стволовых клеток, для индукции адипогенной дифференцировки, регенерации жировой ткани, отбеливания кожи или коррекции морщин
US20160158293A1 (en) *	2014-12-05	2016-06-09	Janssen Biotech, Inc.	Treatment of Ocular Conditions Using Progenitor Cells
WO2016086403A1 (en) *	2014-12-05	2016-06-09	Meridigen Biotech Co., Ltd.	Method of distinguishing mesenchymal stem cells
JP2018500325A (ja) *	2014-12-16	2018-01-11	ヤンセンバイオテツク，インコーポレーテツド	前駆細胞を用いた網膜変性の治療法
US20170080033A1 (en) *	2014-12-16	2017-03-23	Janssen Biotech, Inc.	Treatment of retinal degeneration using progenitor cells
CA2970935A1 (en)	2014-12-19	2016-06-23	Janssen Biotech, Inc.	Suspension culturing of pluripotent stem cells
WO2016111899A1 (en)	2015-01-05	2016-07-14	Petrucci Gary M	Methods and materials for treating lung disorders
WO2016126122A2 (ko) *	2015-02-04	2016-08-11	한양대학교 에리카산학협력단	연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
US11077301B2 (en)	2015-02-21	2021-08-03	NeurostimOAB, Inc.	Topical nerve stimulator and sensor for bladder control
US20160243288A1 (en)	2015-02-23	2016-08-25	Tissuetech, Inc.	Apparatuses and methods for treating ophthalmic diseases and disorders
EP4008775A1 (en)	2015-03-04	2022-06-08	Mesoblast International Sàrl	Cell culture method for mesenchymal stem cells
HK1249461A1 (zh)	2015-03-10	2018-11-02	Allergan Sales, Llc	多针注射器
JP6847044B2 (ja)	2015-03-11	2021-03-24	シーシーエス・ベンチャーズ・リミテッド	肥満及び２型糖尿病（ｔ２ｄ）の治療のための膵内分泌前駆細胞療法
US11027047B2 (en)	2015-03-31	2021-06-08	The University Of North Carolina At Chapel Hill	Delivery vehicles for stem cells and uses thereof
US10286009B2 (en) *	2015-05-16	2019-05-14	Asterias Biotherapeutics, Inc.	Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury
EP3297645A4 (en)	2015-05-20	2018-12-12	Tissuetech, Inc.	Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
CA3177726A1 (en)	2015-05-21	2016-11-24	Musculoskeletal Transplant Foundation	Modified demineralized cortical bone fibers
US10335435B2 (en)	2015-05-22	2019-07-02	Marco Merida	Method for endoscopically delivering stem cells to the brain using an intranasal, injectable approach
WO2017004592A1 (en)	2015-07-02	2017-01-05	Terumo Bct, Inc.	Cell growth with mechanical stimuli
US10384207B2 (en)	2015-07-21	2019-08-20	Neuro Probe Incorporated	Assay apparatus and methods
WO2017019832A1 (en)	2015-07-29	2017-02-02	Medivation Technologies, Inc.	Methods and compositions using repair cells and cationic dyes
WO2017019822A1 (en) *	2015-07-29	2017-02-02	Medivation Technologies, Inc.	Pellet composition containing repair cells
JP6998768B2 (ja)	2015-08-28	2022-02-10	ロート製薬株式会社	Ｒｏｒ１陽性の間葉系幹細胞及びその調製方法、ｒｏｒ１陽性の間葉系幹細胞を含む医薬組成物及びその調製方法、並びにｒｏｒ１陽性の間葉系幹細胞を用いる疾患の予防又は治療方法
USD797290S1 (en)	2015-10-19	2017-09-12	Spinal Surgical Strategies, Llc	Bone graft delivery tool
WO2017087759A1 (en)	2015-11-18	2017-05-26	President And Fellows Of Harvard College	Cartridge-based system for long term culture of cell clusters
US12551509B2 (en)	2015-11-18	2026-02-17	Lucina Patent Holdco, Llc	Acellular regenerative products and methods of their manufacture
SG11201803781XA (en) *	2015-12-04	2018-06-28	Janssen Biotech Inc	Treatment of retinal degeneration using progenitor cells
KR20170076484A (ko) *	2015-12-24	2017-07-04	삼성전자주식회사	프로토카데린의 과발현을 이용한 노화 세포를 분리하는 방법
US10814038B2 (en)	2016-01-06	2020-10-27	3-D Matrix, Ltd.	Combination compositions
US11253551B2 (en)	2016-01-11	2022-02-22	Cedars-Sinai Medical Center	Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
CA3010792A1 (en)	2016-01-14	2017-07-20	DePuy Synthes Products, Inc.	Composition and methods for cryopreservation of hutc
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
WO2017136557A1 (en) *	2016-02-05	2017-08-10	Petrucci Gary M	Methods and materials for treating nerve injuries and neurological disorders
US11458224B2 (en)	2016-03-04	2022-10-04	University of Pittsburgh—of the Commonwealth System of Higher Education	Ovarian-derived hydrogels for biomedical and biotechnology applications
US10478553B2 (en)	2016-03-09	2019-11-19	Orbit Biomedical Limited	Apparatus for subretinal administration of therapeutic agent via a curved needle
GB201604304D0 (en)	2016-03-14	2016-04-27	Tigenix S A U	Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP3223181B1 (en) *	2016-03-24	2019-12-18	Sofradim Production	System and method of generating a model and simulating an effect on a surgical repair site
JP2019509744A (ja)	2016-03-30	2019-04-11	アステリアスバイオセラピューティクスインコーポレイテッド	オリゴデンドロサイト前駆細胞組成物
CN109310827B (zh)	2016-04-08	2021-09-07	阿勒根公司	抽吸和注射装置
CA3020905A1 (en)	2016-04-14	2017-10-19	Janssen Biotech, Inc.	Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
JP7108537B2 (ja)	2016-04-27	2022-07-28	ロート製薬株式会社	Ｃｄ２０１、ｃｄ４６、ｃｄ５６、ｃｄ１４７及びｃｄ１６５からなる群より選択される少なくとも１種の細胞表面マーカーを発現する間葉系幹細胞及びその調製方法、並びに上記間葉系幹細胞を含む医薬組成物及びその調製方法
US11965175B2 (en)	2016-05-25	2024-04-23	Terumo Bct, Inc.	Cell expansion
WO2017210652A1 (en)	2016-06-03	2017-12-07	Cedars-Sinai Medical Center	Cdc-derived exosomes for treatment of ventricular tachyarrythmias
US11685883B2 (en)	2016-06-07	2023-06-27	Terumo Bct, Inc.	Methods and systems for coating a cell growth surface
US11104874B2 (en)	2016-06-07	2021-08-31	Terumo Bct, Inc.	Coating a bioreactor
US11000410B2 (en)	2016-06-17	2021-05-11	Gyroscope Therapeutics Limited	Guide apparatus for tangential entry into suprachoroidal space
US10806629B2 (en)	2016-06-17	2020-10-20	Gyroscope Therapeutics Limited	Injection device for subretinal delivery of therapeutic agent
US10646374B2 (en)	2016-06-17	2020-05-12	Orbit Biomedical Limited	Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent
MA45502A (fr)	2016-06-21	2019-04-24	Janssen Biotech Inc	Génération de cellules bêta fonctionnelles dérivées de cellules souches pluripotentes humaines ayant une respiration mitochondriale glucose-dépendante et une réponse en sécrétion d'insuline en deux phases
US10639398B2 (en)	2016-07-05	2020-05-05	Lifecell Corporation	Tissue matrices incorporating multiple tissue types
MA45623A (fr) *	2016-07-05	2019-05-15	Janssen Biotech Inc	Traitement d'une maladie vasculaire rétinienne utilisant des cellules progénitrices
KR20190055088A (ko) *	2016-08-19	2019-05-22	리젠티스 코퍼레이션	점막 조직의 조직 재구성을 위한 세포외 매트릭스
EP3405204B1 (en) *	2016-08-26	2025-06-25	Restem Llc	Composition and methods of using umbilical cord lining stem cells
EP3515459A4 (en)	2016-09-20	2020-08-05	Cedars-Sinai Medical Center	CELLS DERIVED FROM CARDIOSPHERES AND THEIR EXTRACELLULAR VESICLES TO DELAY OR REVERSE AGING AND AGE-RELATED DISORDERS
MX2019005172A (es)	2016-11-02	2019-09-26	Axogen Corp	Injertos de tejido amniotico y metodos para preparar y usar los mismos.
RU2644306C1 (ru) *	2016-11-22	2018-02-08	Общество с ограниченной ответственностью "ДЖИ-Групп"	Способ восстановления дефектов покровных тканей
WO2018125851A1 (en) *	2016-12-26	2018-07-05	Michael Moeller	Systems and methods to isolate and expand stem cells from urine
US11273072B2 (en)	2017-01-13	2022-03-15	Gyroscope Therapeutics Limited	Suprachoroidal injection device
US10772986B2 (en)	2017-01-26	2020-09-15	Allosource	Fascia fibrous compositions and methods for their use and manufacture
EP3593809A4 (en)	2017-03-08	2021-01-06	Rohto Pharmaceutical Co., Ltd.	PHARMACEUTICAL COMPOSITION CONTAINING MMR1 POSITIVE MESENCHYMATIC STEM CELLS IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF A FIBROSIS-ASSOCIATED DISEASE, ITS PREPARATION PROCESS, AND PROCESS FOR THE PROPHYLACTIC TREATMENT OF FIBROSIS-ASSOCIATED DISEASE OR A FIBROSIS-ASSOCIATED THERAPEUTIC TREATMENT, AND PROCESS FOR THE PROPHYLACTIC TREATMENT OF FIBROSIS ASSOCIATED OR THERAPEUTIC TREATMENT MMR-POSITIVE MESENCHYMATIC STEM CELLS
US11076984B2 (en)	2017-03-13	2021-08-03	Gyroscope Therapeutics Limited	Method of performing subretinal drainage and agent delivery
EP3595680A1 (en)	2017-03-17	2020-01-22	Rutgers, The State University of New Jersey	Compositions and methods for wound healing
US10767164B2 (en)	2017-03-30	2020-09-08	The Research Foundation For The State University Of New York	Microenvironments for self-assembly of islet organoids from stem cells differentiation
US12234441B2 (en)	2017-03-31	2025-02-25	Terumo Bct, Inc.	Cell expansion
US11629332B2 (en)	2017-03-31	2023-04-18	Terumo Bct, Inc.	Cell expansion
US11624046B2 (en)	2017-03-31	2023-04-11	Terumo Bct, Inc.	Cell expansion
CA3059634A1 (en)	2017-04-13	2018-10-18	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
CA3059910A1 (en)	2017-04-19	2018-10-25	Cedars-Sinai Medical Center	Methods and compositions for treating skeletal muscular dystrophy
US10478531B2 (en)	2017-06-22	2019-11-19	Gary M. Petrucci	Methods and materials for treating blood vessels
MX2019015316A (es) *	2017-06-29	2020-07-20	Xintela Ab	Aseguramiento de la calidad de condrocitos.
JP7195033B2 (ja)	2017-07-18	2022-12-23	ザリサーチファウンデイションフォーザステイトユニバーシティーオブニューヨーク	頭蓋内動脈瘤のためのバイオマーカー
US10251917B1 (en)	2017-09-19	2019-04-09	Gary M. Petrucci	Methods and materials for treating tumors
US10821205B2 (en)	2017-10-18	2020-11-03	Lifecell Corporation	Adipose tissue products and methods of production
US11123375B2 (en)	2017-10-18	2021-09-21	Lifecell Corporation	Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
WO2019079672A1 (en)	2017-10-19	2019-04-25	Lifecell Corporation	ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION
US11246994B2 (en)	2017-10-19	2022-02-15	Lifecell Corporation	Methods for introduction of flowable acellular tissue matrix products into a hand
US11629318B2 (en)	2017-10-20	2023-04-18	President And Fellows Of Harvard College	Methods for producing mature adipocytes and methods of use thereof
US20210038650A1 (en) *	2017-10-23	2021-02-11	Cell Medicine, Inc.	Mesenchymal stem cell therapy of leigh syndrome
WO2019087130A2 (en) *	2017-11-03	2019-05-09	Janssen Biotech, Inc.	Method of inhibiting angiogenesis
KR102562469B1 (ko)	2017-11-07	2023-08-01	뉴로스팀 오에이비, 인크.	적응형 회로를 구비한 비침습성 신경 활성화기
WO2019126068A1 (en)	2017-12-20	2019-06-27	Cedars-Sinai Medical Center	Engineered extracellular vesicles for enhanced tissue delivery
US11285177B2 (en)	2018-01-03	2022-03-29	Globus Medical, Inc.	Allografts containing viable cells and methods thereof
CN111565732A (zh)	2018-01-12	2020-08-21	国立大学法人大阪大学	复层扁平上皮细胞的正常分化-成熟促进剂、上皮疾病治疗剂以及复层扁平上皮细胞的正常分化-成熟促进方法
US20190218521A1 (en) *	2018-01-18	2019-07-18	Lorenzo Bracco	Culture medium of viruses for human vaccines have to consist of human cells from placenta and/or from umbilical cord of a fetus of the blood type 0 Rh- and of the mother of the blood type 0 Rh- (both, fetus and mother, must be of the blood type 0 Rh-)
WO2019152483A1 (en) *	2018-01-30	2019-08-08	University Of Georgia Research Foundation, Inc.	Methods for vascular construction and products therefrom
WO2019152549A1 (en)	2018-02-05	2019-08-08	Cedars-Sinai Medical Center	Methods for therapeutic use of exosomes and y-rnas
CN108384752A (zh) *	2018-02-13	2018-08-10	中国人民解放军第四五五医院	成软骨培养基及其在微分裂技术中膝关节软骨分化中的应用
US12453743B2 (en)	2018-05-30	2025-10-28	Direct Biologics, Llc	Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use
CN108961233A (zh) *	2018-06-28	2018-12-07	华侨大学	一种聚晶金刚石复合片表面缺陷分类识别方法
AU2019342741B2 (en)	2018-09-19	2025-12-11	Lineage Cell Therapeutics, Inc.	Methods for differentiating pluripotent stem cells in dynamic suspension culture
US11419898B2 (en)	2018-10-17	2022-08-23	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
JP2022512766A (ja)	2018-10-17	2022-02-07	センティバイオサイエンシズインコーポレイテッド	組み合わせがん免疫療法
JP7469317B2 (ja)	2019-01-23	2024-04-16	アステリアスバイオセラピューティクスインコーポレイテッド	ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞
KR20210137026A (ko)	2019-02-07	2021-11-17	다이렉트 바이오로직스 엘엘씨	중간엽 줄기세포 엑소좀, 활액 중간엽 줄기세포 및 스캐폴드의 조합을 이용한 골관절염 치료 방법
US12391924B2 (en)	2019-02-08	2025-08-19	Regrow Biosciences Private Limited	Method for mesenchymal stem cell isolation and osteoblast differentiation
US11759355B1 (en)	2019-02-26	2023-09-19	Gyroscope Therapeutics Limited	Method of delivering leading blebs and agent to subretinal space
KR102169924B1 (ko) *	2019-03-26	2020-10-26	연세대학교 산학협력단	연골세포 분화 유도용 조성물 및 이의 용도
KR102167257B1 (ko) *	2019-05-28	2020-10-19	부산대학교 산학협력단	토마티딘 처리를 통한 줄기세포의 성숙화된 심근세포로의 분화유도 촉진 방법
AU2020283895A1 (en)	2019-05-30	2022-01-06	Lifecell Corporation	Biologic breast implant
CN114126704B (zh)	2019-06-26	2026-02-03	神经科学技术有限责任公司	具有自适应电路的非侵入性神经激活器
EP3999083A4 (en)	2019-07-18	2023-07-26	Direct Biologics LLC	Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
KR20220047879A (ko) *	2019-08-29	2022-04-19	아지노모토 가부시키가이샤	간엽계 줄기세포를 포함한 생체 유래 세포 시료로부터 간엽계 줄기세포를 제조하는 방법
US20220330530A1 (en) *	2019-09-13	2022-10-20	The University Of North Carolina At Chapel Hill	Method of making human mouse xenografts
KR20220080145A (ko) *	2019-10-07	2022-06-14	유니버시티 오브 유타 리서치 파운데이션	연골원성 인간 중간엽 줄기 세포 (msc) 시트
WO2021069968A1 (en)	2019-10-11	2021-04-15	Gyroscope Therapeutics Limited	Dose clip assembly for syringe
WO2021092199A1 (en)	2019-11-08	2021-05-14	Kansas State University Research Foundation	Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells
TWI776276B (zh) *	2019-11-13	2022-09-01	中國醫藥大學	異種組織細胞組合物治療癌症之用途
EP4017580A4 (en)	2019-12-16	2023-09-06	Neurostim Technologies LLC	NON-INVASIVE NERVE ACTIVATOR WITH ENHANCED CHARGE DELIVERY
US20230159932A1 (en)	2020-04-22	2023-05-25	Direct Biologics Llc	Methods and compositions for treating inflammatory conditions associated with infectious disease
WO2021226373A2 (en)	2020-05-08	2021-11-11	Gallant Pet, Inc.	Uterine-derived regenerative cell compositions and uses thereof
CN111718410B (zh) *	2020-06-05	2022-10-11	江南大学	一种制备卵黄免疫球蛋白的方法
JP6967308B1 (ja) *	2020-06-30	2021-11-17	国立大学法人高知大学	胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN113755432B (zh) *	2020-07-17	2022-06-10	上海我武干细胞科技有限公司	干细胞培养方法
WO2022046954A1 (en) *	2020-08-25	2022-03-03	Celularity Inc.	Appl cells improved placental-derived adherent cells and methods of their use
CN114246985A (zh) *	2020-09-25	2022-03-29	华东理工大学	一种类骨膜组织的仿生构建方法
US12347100B2 (en)	2020-11-19	2025-07-01	Mazor Robotics Ltd.	Systems and methods for generating virtual images
EP4259053A1 (en)	2020-12-22	2023-10-18	Gyroscope Therapeutics Limited	Ocular cannula guide
EP4279919A4 (en) *	2021-01-12	2025-01-08	Cellatoz Therapeutics, Inc.	Method for screening neuronal regeneration promoting cells having neuronal regeneration activity
CN116802501A (zh) *	2021-01-12	2023-09-22	雪拉托兹治疗株式会社	具有神经元再生活性的神经元再生促进细胞的筛选方法
EP4314244B1 (en)	2021-03-23	2025-07-23	Terumo BCT, Inc.	Cell capture and expansion
WO2023111959A1 (en) *	2021-12-17	2023-06-22	3M Innovative Properties Company	Wound dressings and methods of making the same
US12152699B2 (en)	2022-02-28	2024-11-26	Terumo Bct, Inc.	Multiple-tube pinch valve assembly
US12435312B2 (en)	2022-02-28	2025-10-07	Brown University	Quantifying cell-derived changes in collagen synthesis, alignment, and mechanics in a 3D connective tissue model
CN115068438B (zh) *	2022-04-28	2023-09-22	浙江大学医学院附属邵逸夫医院	破骨细胞前体同源靶向的细胞膜纳米囊泡制备方法及应用
ES2956802B2 (es) *	2022-05-20	2025-10-02	Bioiberica S A U	Hidrogeles para su uso en ingenieria de tejidos de la piel
CN115044542B (zh) *	2022-06-30	2023-09-26	上海市东方医院（同济大学附属东方医院）	Sj000291942在诱导间充质干细胞成骨分化方面的应用
JPWO2024024708A1 (pl) *	2022-07-26	2024-02-01
USD1099116S1 (en)	2022-09-01	2025-10-21	Terumo Bct, Inc.	Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
JP2025527930A (ja)	2022-09-06	2025-08-22	ジェネンテック，インコーポレイテッド	二重湾曲針を介した治療剤の網膜下投与のための装置
EP4379046A1 (en)	2022-11-30	2024-06-05	Universidade Nova De Lisboa	A 3d cellular model of early diabetic retinopathy
WO2024116114A1 (en)	2022-11-30	2024-06-06	Universidade Nova De Lisboa	A 3d cellular model of early diabetic retinopathy
CN116218769B (zh) *	2023-01-03	2025-09-05	深圳市汉科生物工程有限公司	一种促进软骨细胞生长的方法
JP2026500975A (ja)	2023-01-13	2026-01-09	ジェネンテック，インコーポレイテッド	シリンジのための投与ドック
WO2024172859A1 (en) *	2023-02-17	2024-08-22	Spine Biopharma, Inc.	Peptide formulations
WO2025072590A1 (en)	2023-09-29	2025-04-03	Genentech, Inc.	Ocular cannula guide, applicator, and marking instrument
WO2025080727A1 (en) *	2023-10-10	2025-04-17	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Autologous serum insert for treating an ocular condition
WO2025207699A1 (en)	2024-03-27	2025-10-02	Genentech, Inc.	Torque ring for subretinal injection device
US12502407B2 (en)	2024-04-25	2025-12-23	Direct Biologics, Llc	Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (326)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US229971A (en)		1880-07-13		Ttornets
US2324800A (en)	1941-08-14	1943-07-20	Pfizer Charles & Co	Purification of riboflavin
US2654735A (en) *	1949-07-29	1953-10-06	Us Vitamin Corp	Process for the production of derivatives of 9-polyhydroxyalkylisoalloxazines and products obtained
US2864848A (en)	1954-07-19	1958-12-16	Ca Nat Research Council	Method of producing l-alpha-glycerylphosphorylcholine
US2912332A (en) *	1958-02-27	1959-11-10	Swift & Co	Stabilized thiamine composition and method of enriching food products
US3665061A (en)	1969-07-16	1972-05-23	United States Banknote Corp	Process for producing collagen sponges
JPS5651747B2 (pl)	1973-05-31	1981-12-08
CH635748A5 (fr)	1977-08-16	1983-04-29	Cellorgan Laboratoires Sa	Procede d'obtention de cellules placentaires de brebis.
US4216144A (en) *	1977-10-20	1980-08-05	Ashmead H H	Soluble iron proteinates
JPS6040439B2 (ja)	1978-03-29	1985-09-11	大正製薬株式会社	ヒドロコルチゾン誘導体
US4352883A (en)	1979-03-28	1982-10-05	Damon Corporation	Encapsulation of biological material
US4393240A (en) *	1981-07-06	1983-07-12	Stille John K	Optically active phosphines
US4544516A (en)	1982-07-28	1985-10-01	Battelle Development Corporation	Collagen orientation
US4465776A (en)	1982-09-27	1984-08-14	Research Corporation	Monoclonal antibodies to vitamin B6 and immunoassay method
US4657866A (en)	1982-12-21	1987-04-14	Sudhir Kumar	Serum-free, synthetic, completely chemically defined tissue culture media
US4487865A (en)	1983-12-15	1984-12-11	Biomatrix, Inc.	Polymeric articles modified with hyaluronate
US5902741A (en)	1986-04-18	1999-05-11	Advanced Tissue Sciences, Inc.	Three-dimensional cartilage cultures
US4963489A (en)	1987-04-14	1990-10-16	Marrow-Tech, Inc.	Three-dimensional cell and tissue culture system
US5863531A (en) *	1986-04-18	1999-01-26	Advanced Tissue Sciences, Inc.	In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5266480A (en)	1986-04-18	1993-11-30	Advanced Tissue Sciences, Inc.	Three-dimensional skin culture system
US4925667A (en)	1986-05-27	1990-05-15	Qmax Technology Group, Inc.	Substrate with particulate cosmetic
JPS642643A (en)	1987-06-26	1989-01-06	Bio Material Yunibaasu:Kk	Artificial skin
NZ226750A (en)	1987-10-29	1990-09-26	Amrad Corp Ltd	Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5192553A (en) *	1987-11-12	1993-03-09	Biocyte Corporation	Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5004681B1 (en) *	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5162405A (en) *	1987-12-24	1992-11-10	Elf Atochem North America, Inc.	Single-functional and mixtures of multi-functional oligomeric performance additive compositions and their uses
GB8803697D0 (en)	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
US4963439A (en)	1988-04-19	1990-10-16	Ube Industries, Ltd.	Continuous fiber-reinforced Al-Co alloy matrix composite
US20030032178A1 (en) *	1988-08-04	2003-02-13	Williams Robert Lindsay	In vitro propagation of embryonic stem cells
US5618670A (en) *	1988-08-26	1997-04-08	The United States Of America As Represented By The Department Of Health & Human Services	Detection method for c-raf-1 genes
US4925677A (en)	1988-08-31	1990-05-15	Theratech, Inc.	Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5284766A (en) *	1989-02-10	1994-02-08	Kao Corporation	Bed material for cell culture
JPH06104061B2 (ja)	1989-02-10	1994-12-21	花王株式会社	細胞培養支持体材料
DE69009237T2 (de) *	1989-02-27	1994-12-01	Takasago Perfumery Co Ltd	Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
FR2646438B1 (fr)	1989-03-20	2007-11-02	Pasteur Institut	Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
US5437994A (en) *	1989-06-15	1995-08-01	Regents Of The University Of Michigan	Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5574205A (en)	1989-07-25	1996-11-12	Cell Genesys	Homologous recombination for universal donor cells and chimeric mammalian hosts
US5840580A (en)	1990-05-01	1998-11-24	Becton Dickinson And Company	Phenotypic characterization of the hematopoietic stem cell
US5145770A (en) *	1990-06-04	1992-09-08	Biosurface Technology, Inc.	Cryopreservation of cultured epithelial sheets
WO1992003917A1 (en)	1990-08-29	1992-03-19	Genpharm International	Homologous recombination in mammalian cells
US5336616A (en) *	1990-09-12	1994-08-09	Lifecell Corporation	Method for processing and preserving collagen-based tissues for transplantation
US5342761A (en)	1990-10-01	1994-08-30	Research Development Foundation	Oncofetal gene, gene product and uses therefor
US5506134A (en)	1990-10-22	1996-04-09	Corvas International, Inc.	Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5811094A (en)	1990-11-16	1998-09-22	Osiris Therapeutics, Inc.	Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) *	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
US5140100A (en) *	1990-12-28	1992-08-18	Cedars-Sinai Medical Center	Protein that inhibits production of human choriogonadotropin
US5286632A (en) *	1991-01-09	1994-02-15	Jones Douglas H	Method for in vivo recombination and mutagenesis
NL9100038A (nl)	1991-01-11	1992-08-03	Stamicarbon	Enzym-gekatalyseerde bereiding van optisch aktieve carbonzuren.
WO1992019249A1 (en)	1991-05-02	1992-11-12	Yeda Research And Development Co. Ltd.	Compositions for the prevention and/or treatment of pathological processes
US6399369B1 (en) *	1991-07-08	2002-06-04	Neurospheres Holdings Ltd.	Multipotent neural stem cell cDNA libraries
EP0552380A4 (en)	1991-08-08	1995-01-25	Kao Corp	Cell culture support, production thereof, and production of cell cluster using same
EP0529751A1 (en)	1991-08-09	1993-03-03	W.R. Grace & Co.-Conn.	Cell culture substrate, test material for cell culture and preparations thereof
WO1993004169A1 (en)	1991-08-20	1993-03-04	Genpharm International, Inc.	Gene targeting in animal cells using isogenic dna constructs
WO1993006726A1 (en) *	1991-09-30	1993-04-15	Mackenzie Walser	Methods for treatment of free-radical-mediated tissue injury
US5308763A (en) *	1991-10-01	1994-05-03	The Johns Hopkins University	Method of making primary culture of olfactory neurons
US5914265A (en) *	1992-04-30	1999-06-22	Baylor College Of Medicine	Keratin K1 expression vectors and methods of use
AU4543193A (en)	1992-06-22	1994-01-24	Henry E. Young	Scar inhibitory factor and use thereof
US5320962A (en)	1992-07-22	1994-06-14	Duke University	DNA encoding the human A1 adenosine receptor
US5589376A (en)	1992-07-27	1996-12-31	California Institute Of Technology	Mammalian neural crest stem cells
US5356807A (en) *	1992-09-08	1994-10-18	Cornell Research Foundation	Cultured cell line of adult diploid cells from human brain and meningeal tissue
US20040224409A1 (en)	1992-09-25	2004-11-11	Laurent Pradier	Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
WO1994010331A1 (en)	1992-10-29	1994-05-11	The Australian National University	Angiogenesis inhibitory antibodies
US5670483A (en)	1992-12-28	1997-09-23	Massachusetts Insititute Of Technology	Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5955343A (en)	1992-12-28	1999-09-21	Massachusetts Institute Of Technology	Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5707643A (en)	1993-02-26	1998-01-13	Santen Pharmaceutical Co., Ltd.	Biodegradable scleral plug
WO1994022451A1 (en) *	1993-04-07	1994-10-13	Oklahoma Medical Research Foundation	Selective regulation of b lymphocyte precursors by hormones
WO1994025584A1 (en)	1993-04-28	1994-11-10	Johns Hopkins University School Of Medicine	Chronic endothelial cell culture under flow
IL110589A0 (en)	1993-08-10	1994-11-11	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF- beta family
JP3680114B2 (ja)	1993-09-17	2005-08-10	敏一中村	脳神経障害治療剤
US6686198B1 (en)	1993-10-14	2004-02-03	President And Fellows Of Harvard College	Method of inducing and maintaining neuronal cells
US6432711B1 (en)	1993-11-03	2002-08-13	Diacrin, Inc.	Embryonic stem cells capable of differentiating into desired cell lines
US5456835A (en) *	1993-11-08	1995-10-10	Hemasure, Inc.	Device and process for removing free hemoglobin from blood
DE4406073A1 (de) *	1994-02-24	1995-08-31	Univ Ludwigs Albert	Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten
US5698518A (en)	1994-03-30	1997-12-16	Oklahoma Medical Research Foundation	Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
US5466233A (en)	1994-04-25	1995-11-14	Escalon Ophthalmics, Inc.	Tack for intraocular drug delivery and method for inserting and removing same
US6001647A (en)	1994-04-28	1999-12-14	Ixion Biotechnology, Inc.	In vitro growth of functional islets of Langerhans and in vivo uses thereof
US6703017B1 (en)	1994-04-28	2004-03-09	Ixion Biotechnology, Inc.	Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US5834308A (en)	1994-04-28	1998-11-10	University Of Florida Research Foundation, Inc.	In vitro growth of functional islets of Langerhans
CA2192103C (en)	1994-06-06	2002-02-05	Arnold I. Caplan	Biomatrix for tissue regeneration
IL114397A0 (en)	1994-07-01	1995-10-31	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF-beta-family
US5935849A (en) *	1994-07-20	1999-08-10	Cytotherapeutics, Inc.	Methods and compositions of growth control for cells encapsulated within bioartificial organs
US6309853B1 (en)	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5660982A (en) *	1994-10-04	1997-08-26	Tryggvason; Karl	Laminin chains: diagnostic uses
US5789147A (en)	1994-12-05	1998-08-04	New York Blood Center, Inc.	Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5725493A (en) *	1994-12-12	1998-03-10	Avery; Robert Logan	Intravitreal medicine delivery
US5684032A (en)	1994-12-13	1997-11-04	Smithkline Beecham Corporation	Compounds
US5843780A (en)	1995-01-20	1998-12-01	Wisconsin Alumni Research Foundation	Primate embryonic stem cells
US5736396A (en)	1995-01-24	1998-04-07	Case Western Reserve University	Lineage-directed induction of human mesenchymal stem cell differentiation
US5906934A (en)	1995-03-14	1999-05-25	Morphogen Pharmaceuticals, Inc.	Mesenchymal stem cells for cartilage repair
US5718922A (en) *	1995-05-31	1998-02-17	Schepens Eye Research Institute, Inc.	Intravitreal microsphere drug delivery and method of preparation
US5869079A (en) *	1995-06-02	1999-02-09	Oculex Pharmaceuticals, Inc.	Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5693332C1 (en)	1995-08-11	2001-01-09	Univ California	Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5641750A (en) *	1995-11-29	1997-06-24	Amgen Inc.	Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US6200606B1 (en) *	1996-01-16	2001-03-13	Depuy Orthopaedics, Inc.	Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5842477A (en)	1996-02-21	1998-12-01	Advanced Tissue Sciences, Inc.	Method for repairing cartilage
CA2248549A1 (en)	1996-03-15	1997-09-18	Munin Corporation	Extracellular matrix signalling molecules
US6223188B1 (en) *	1996-04-10	2001-04-24	Sun Microsystems, Inc.	Presentation of link information as an aid to hypermedia navigation
AU2808397A (en)	1996-04-26	1997-11-19	Case Western Reserve University	Skin regeneration using mesenchymal stem cells
US6358737B1 (en)	1996-07-31	2002-03-19	Board Of Regents, The University Of Texas System	Osteocyte cell lines
US6787355B1 (en)	1996-08-26	2004-09-07	Mcgill University	Multipotent neural stem cells from peripheral tissues and uses thereof
US5919702A (en)	1996-10-23	1999-07-06	Advanced Tissue Science, Inc.	Production of cartilage tissue using cells isolated from Wharton's jelly
WO1998031316A1 (en) *	1997-01-17	1998-07-23	Celadon Science, Llc	Methods for promoting healing of corneal resurfacing wounds
AU6144698A (en)	1997-02-05	1998-08-25	Case Western Reserve University	Stimulatory effects of bfgf and bmp-2 on osteogenic differentiation of mesenchymal stem cells
WO1998051317A1 (en)	1997-05-13	1998-11-19	Osiris Therapeutics, Inc.	Osteoarthritis cartilage regeneration using human mesenchymal stem cells
CA2290381A1 (en)	1997-05-21	1998-11-26	Sloan-Kettering Institute For Cancer Research	Method for increasing the concentration of ascorbic acid in brain tissues of a subject
AU738334B2 (en)	1997-05-30	2001-09-13	Osteobiologics, Inc.	Fiber-reinforced, porous, biodegradable implant device
ATE307195T1 (de)	1997-07-14	2005-11-15	Osiris Therapeutics Inc	Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
US5902598A (en) *	1997-08-28	1999-05-11	Control Delivery Systems, Inc.	Sustained release drug delivery devices
ES2351082T3 (es) *	1997-12-02	2011-01-31	Artecel Sciences, Inc.	Diferenciación de células estromales adiposas en osteoblastos y sus usos.
US6059968A (en)	1998-01-20	2000-05-09	Baxter International Inc.	Systems for processing and storing placenta/umbilical cord blood
US6291240B1 (en) *	1998-01-29	2001-09-18	Advanced Tissue Sciences, Inc.	Cells or tissues with increased protein factors and methods of making and using same
PT1062321E (pt)	1998-03-13	2005-05-31	Osiris Therapeutics Inc	Utilizacoes para celulas estaminais mesenquimais humanas nao autologas
EP1076563B1 (en)	1998-03-16	2005-05-11	Cytovia, Inc.	Dipeptide caspase inhibitors and the use thereof
US6179872B1 (en)	1998-03-17	2001-01-30	Tissue Engineering	Biopolymer matt for use in tissue repair and reconstruction
US6171610B1 (en)	1998-04-24	2001-01-09	University Of Massachusetts	Guided development and support of hydrogel-cell compositions
JP2002513545A (ja)	1998-05-07	2002-05-14	ザユニヴァーシティーオブサウスフロリダ	脳および脊髄修復のためのニューロン源としての骨髄細胞
ES2292245T3 (es) *	1998-05-29	2008-03-01	Osiris Therapeutics, Inc.	Celulas madre mesenquimaticas cd45+ y/o fibroblasto+humanas.
US6323188B1 (en)	1998-07-01	2001-11-27	Donald L. Weissman	Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins
DE19833340A1 (de)	1998-07-24	2000-02-10	Karlsruhe Forschzent	Wurmförmiger Arbeitsmechanismus
US20040037818A1 (en)	1998-07-30	2004-02-26	Brand Stephen J.	Treatment for diabetes
ATE445006T1 (de)	1998-08-10	2009-10-15	Us Gov Health & Human Serv	Differenzierung von nicht-insulin in insulin- produzierende zellen durch glp-1 und exendin-4 und dessen verwendung
US5958767A (en) *	1998-08-14	1999-09-28	The Children's Medical Center Corp.	Engraftable human neural stem cells
US6284245B1 (en)	1998-08-25	2001-09-04	Diacrin, Inc.	Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
US6444205B2 (en)	1998-09-30	2002-09-03	Diacrin, Inc.	Transplantation of neural cells for the treatment of chronic pain or spasticity
US6610540B1 (en)	1998-11-18	2003-08-26	California Institute Of Technology	Low oxygen culturing of central nervous system progenitor cells
US6241369B1 (en) *	1998-11-20	2001-06-05	Cooper Technologies Company	Quick mount fixture
US6144054A (en) *	1998-12-04	2000-11-07	International Business Machines Corporation	DRAM cell having an annular signal transfer region
DE19856428C1 (de) *	1998-12-08	2000-05-04	Heraeus Noblelight Gmbh	Entladungslampe
AU1675600A (en)	1998-12-24	2000-07-31	Biosafe S.A.	Blood separation system particularly for concentrating hematopoietic stem cells
JP4932069B2 (ja)	1999-01-25	2012-05-16	株式会社セルシード	アクリルアミド誘導体および該誘導体を含む重合体
CA2359821A1 (en)	1999-02-04	2000-08-10	Mcgill University	Platform for the differentiation of cells
AU780794B2 (en)	1999-02-10	2005-04-14	Es Cell International Pte Ltd	Pancreatic progenitor cells, methods and uses related thereto
US6592623B1 (en)	1999-08-31	2003-07-15	Virginia Commonwealth University Intellectual Property Foundation	Engineered muscle
RU2306335C2 (ru)	1999-03-10	2007-09-20	Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн	Стволовые клетки и решетки, полученные из жировой ткани
US20030007954A1 (en)	1999-04-12	2003-01-09	Gail K. Naughton	Methods for using a three-dimensional stromal tissue to promote angiogenesis
JP2002542349A (ja)	1999-04-16	2002-12-10	ダブリューエム・マーシュ・ライス・ユニバーシティー	ポリ（プロピレンフマラート）−ジアクリレートマクロマーで交差結合された生体分解性のポリ（プロピレンフマラート）ネットワーク
US7371400B2 (en)	2001-01-02	2008-05-13	The General Hospital Corporation	Multilayer device for tissue engineering
US6261600B1 (en)	1999-04-30	2001-07-17	Drugtech Corporation	Folic acid supplement
US6287340B1 (en)	1999-05-14	2001-09-11	Trustees Of Tufts College	Bioengineered anterior cruciate ligament
US6372494B1 (en)	1999-05-14	2002-04-16	Advanced Tissue Sciences, Inc.	Methods of making conditioned cell culture medium compositions
AU4860900A (en)	1999-06-02	2000-12-18	Lifebank Services, L.L.C.	Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
US6329904B1 (en) *	1999-06-11	2001-12-11	Safety Through Cellular, Inc.	Apparatus and method for providing weather and other alerts
WO2001000788A2 (en)	1999-06-25	2001-01-04	Northwestern University	Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
US6333029B1 (en) *	1999-06-30	2001-12-25	Ethicon, Inc.	Porous tissue scaffoldings for the repair of regeneration of tissue
US6355699B1 (en)	1999-06-30	2002-03-12	Ethicon, Inc.	Process for manufacturing biomedical foams
ATE514772T1 (de)	1999-08-05	2011-07-15	Abt Holding Co	Multipotente erwachsene stammzellen und verfahren zu deren isolierung
US6429013B1 (en)	1999-08-19	2002-08-06	Artecel Science, Inc.	Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6555374B1 (en)	1999-08-19	2003-04-29	Artecel Sciences, Inc.	Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
EP1216049A2 (en)	1999-09-14	2002-06-26	Children's Medical Center Corporation	Methods for treating muscular dystrophy with bone marrow cells
US6331313B1 (en)	1999-10-22	2001-12-18	Oculex Pharmaceticals, Inc.	Controlled-release biocompatible ocular drug delivery implant devices and methods
US20030129745A1 (en)	1999-10-28	2003-07-10	Robl James M.	Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
EP1099754A1 (en)	1999-11-10	2001-05-16	Universiteit Leiden	Mesenchymal stem cells and/or progenitor cells, their isolation and use
EP1257282A4 (en)	1999-12-06	2003-05-02	Gen Hospital Corp	PANCREATIC STEM CELLS AND THEIR USE IN TRANSPLANTATION
US20030082155A1 (en) *	1999-12-06	2003-05-01	Habener Joel F.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US20020164307A1 (en)	1999-12-06	2002-11-07	Habener Joel F.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
WO2001053503A1 (en)	2000-01-18	2001-07-26	Cornell Research Foundation, Inc.	Neural progenitor cells from hippocampal tissue and a method for isolating and purifying them
US7544509B2 (en)	2000-01-24	2009-06-09	Mcgill University	Method for preparing stem cell preparations
US6610535B1 (en)	2000-02-10	2003-08-26	Es Cell International Pte Ltd.	Progenitor cells and methods and uses related thereto
JP2003521935A (ja)	2000-02-11	2003-07-22	フイラデルフイア・ヘルス・アンド・エデユケーシヨン・コーポレーシヨン	骨髄細胞のニューロン細胞への分化およびそのための使用
AU2001234998B2 (en)	2000-02-11	2006-06-08	Childrens Hospital Of Orange County A California Corporation	Isolation and transplantation of retinal stem cells
US7160724B2 (en) *	2000-03-09	2007-01-09	University Of South Florida	Human cord blood as a source of neural tissue for repair of the brain and spinal cord
AU2001245550A1 (en) *	2000-03-09	2001-09-17	Lee Walters	Applications of immune system tolerance to treatment of various diseases
EP2298858A1 (en)	2000-03-16	2011-03-23	Cellseed Inc.	Bed material for cell culture, method for co-culture of cell and co-cultured cell sheet obtainable therefrom
US6436704B1 (en)	2000-04-10	2002-08-20	Raven Biotechnologies, Inc.	Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US6673606B1 (en) *	2000-04-12	2004-01-06	The Children's Hospital Of Philadelphia	Therapeutic uses for mesenchymal stromal cells
US6375972B1 (en)	2000-04-26	2002-04-23	Control Delivery Systems, Inc.	Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
AU6459801A (en)	2000-05-12	2001-11-26	Mark T Keating	Compositions and methods for cell dedifferentiation and tissue regeneration
US8273570B2 (en)	2000-05-16	2012-09-25	Riken	Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
US7049072B2 (en)	2000-06-05	2006-05-23	University Of South Florida	Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
US6759039B2 (en)	2000-06-30	2004-07-06	Amcyte, Inc.	Culturing pancreatic stem cells having a specified, intermediate stage of development
EP2275532B1 (en)	2000-07-21	2012-06-06	Cellseed Inc.	Myocardium-like cell sheets and processes for producing them
JP4716479B2 (ja) *	2000-07-21	2011-07-06	株式会社セルシード	表皮培養細胞シート、重層化培養皮膚シート、及びそれらの製造法
US6984522B2 (en)	2000-08-03	2006-01-10	Regents Of The University Of Michigan	Isolation and use of solid tumor stem cells
DE10038814A1 (de) *	2000-08-09	2002-02-21	Abb Research Ltd	Hochspannungs-Gleichstromwandler
CA2424062A1 (en)	2000-09-29	2002-04-04	Derek Van Der Kooy	Primitive neural stem cells and method for differentiation of stem cells to neural cells
US6639470B1 (en)	2000-10-06	2003-10-28	Skyworks Solutions, Inc.	Constant current biasing circuit for linear power amplifiers
US7560280B2 (en)	2000-11-03	2009-07-14	Kourion Therapeutics Gmbh	Human cord blood derived unrestricted somatic stem cells (USSC)
US20020098584A1 (en)	2000-11-06	2002-07-25	Palmer Theo D.	Postmortem stem cells
JP2004532648A (ja)	2000-11-30	2004-10-28	ステムロンインコーポレイテッド	単離されたホモ接合性幹細胞、これ由来の分化細胞、ならびにこれを作製及び使用するための材料及び方法
DK1349918T3 (da)	2000-12-06	2014-11-10	Anthrogenesis Corp	Fremgangsmåde til indsamling af stamceller fra moderkagen
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US7311904B2 (en)	2001-02-14	2007-12-25	Anthrogenesis Corporation	Tissue matrices comprising placental stem cells, and methods of making the same
US6599323B2 (en)	2000-12-21	2003-07-29	Ethicon, Inc.	Reinforced tissue implants and methods of manufacture and use
CA2365376C (en)	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
WO2002059278A2 (en)	2001-01-24	2002-08-01	The Government Of The United States Of America, As Represented By The Secretary Of Department Of Health & Human Services	Differentiation of stem cells to pancreatic endocrine cells
WO2002061053A1 (en)	2001-01-31	2002-08-08	The General Hospital Corporation	Renal stem cells and uses thereof
US7449180B2 (en)	2001-02-06	2008-11-11	John Kisiday	Macroscopic scaffold containing amphiphilic peptides encapsulating cells
DE60230593D1 (de)	2001-02-06	2009-02-12	Massachusetts Inst Technology	Peptidgerüstverkapselung von gewebszellen und verwendungen davon
IL157350A0 (en) *	2001-02-14	2004-02-19	Anthrogenesis Corp	Post-partum mammalian placenta, its use and placental stem cells therefrom
EP1367899A4 (en)	2001-02-14	2004-07-28	Leo T Furcht	TOTIPOTENT ADULT STEM CELLS, SOURCES OF SUCH CELLS, METHODS FOR OBTAINING AND MAINTAINING SAME, METHODS FOR DIFFERENTIATING THESE CELLS, METHODS OF USING SAME, AND CELLS DERIVED FROM THE ABOVE-MENTIONED CELLS
CA2441986A1 (en) *	2001-03-27	2002-10-03	Massachusetts Institute Of Technology	Methods and products related to fgf dimerization
US7838292B1 (en)	2001-03-29	2010-11-23	University Of Louisville Research Foundation, Inc.	Methods for obtaining adult human olfactory progenitor cells
US7202080B2 (en)	2001-03-29	2007-04-10	Ixion Biotechnology, Inc.	Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
WO2002086107A2 (en)	2001-04-19	2002-10-31	DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung	A method for differentiating stem cells into insulin-producing cells
KR100762261B1 (ko)	2001-04-27	2007-10-04	(주)바이오니아	전장 상보 디옥시리보핵산 제조 방법과 이에 사용되는앵커와 프라이머
US20030211605A1 (en)	2001-05-01	2003-11-13	Lee Sang-Hun	Derivation of midbrain dopaminergic neurons from embryonic stem cells
US20030022369A1 (en) *	2001-05-18	2003-01-30	Helen Fillmore	Differentiation of specialized dermal and epidermal cells into neuronal cells
WO2002096203A1 (en)	2001-05-25	2002-12-05	Cythera, Inc.	Stem cell differentiation
AU2002345603B2 (en)	2001-06-07	2006-10-12	Skinmedica, Inc.	Conditioned cell culture media and uses thereof
RU2183966C1 (ru)	2001-07-06	2002-06-27	Общество с ограниченной ответственностью "Сибларекс"	Состав биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий и способ получения биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий
US6402263B1 (en)	2001-07-24	2002-06-11	Robert Bosch Corporation	Dual actuation master cylinder
EP1423504B1 (en)	2001-08-08	2009-09-23	Levesque Biosciences, Inc.	Compositions and methods for isolation, propagation, and differentiation of non-embryonic human stem cells and uses thereof
US20030211603A1 (en)	2001-08-14	2003-11-13	Earp David J.	Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
AU2002313817A1 (en) *	2001-08-27	2003-03-10	Advanced Cell Technology, Inc.	Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
US20030104997A1 (en) *	2001-09-05	2003-06-05	Black Ira B.	Multi-lineage directed induction of bone marrow stromal cell differentiation
CN1195055C (zh)	2001-09-06	2005-03-30	周胜利	从胎盘组织中提取造血干细胞用于建立造血干细胞库的新方法
US20050064587A1 (en)	2001-09-07	2005-03-24	Lawrence Rosenberg	Pancreatic small cells and uses thereof
US9969980B2 (en)	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US7072332B2 (en) *	2001-09-27	2006-07-04	Samsung Electronics Co., Ltd.	Soft switch using distributed firewalls for load sharing voice-over-IP traffic in an IP network
EP1298201A1 (en)	2001-09-27	2003-04-02	Cardion AG	Process for the production of cells exhibiting an islet-beta-cell-like state
GB2396623B (en)	2001-09-28	2006-04-05	Es Cell Int Pte Ltd	Methods of derivation and propagation of undifferentiated human embryonic stem (hes) cells on feeder-free matrices and human feeder layers
WO2003033697A1 (en)	2001-10-18	2003-04-24	Ixion Biotechnology, Inc.	Conversion of liver stem and progenitor cells to pancreatic functional cells
US7129034B2 (en)	2001-10-25	2006-10-31	Cedars-Sinai Medical Center	Differentiation of whole bone marrow
US20030124721A1 (en)	2001-11-09	2003-07-03	Bentley Cheatham	Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
WO2003054146A2 (en)	2001-11-14	2003-07-03	Northwestern University	Self-assembly and mineralization of peptide-amphiphile nanofibers
WO2003042405A2 (en)	2001-11-15	2003-05-22	Children's Medical Center Corporation	Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
JP3728750B2 (ja) *	2001-11-22	2005-12-21	ニプロ株式会社	培養皮膚及びその製造方法
CN1596130A (zh)	2001-11-28	2005-03-16	安琪士多摩奇株式会社	治疗神经退行性疾病的基因治疗药物
US6712850B2 (en)	2001-11-30	2004-03-30	Ethicon, Inc.	Porous tissue scaffolds for the repair and regeneration of dermal tissue
WO2003048336A2 (en)	2001-12-04	2003-06-12	Organogenesis Inc.	Cultured cells from pancreatic islets
WO2003054171A1 (en)	2001-12-06	2003-07-03	The Regents Of The University Of California	Method for differentiating islet precursor cells into beta cells
TW200301132A (en) *	2001-12-06	2003-07-01	Sankyo Co	Pharmaceutical compositions containing cells derived from human caul
US7033831B2 (en) *	2001-12-07	2006-04-25	Geron Corporation	Islet cells from human embryonic stem cells
AU2002364558A1 (en) *	2001-12-11	2003-06-23	Cytograft Tissue Engineering, Inc.	Tissue engineered cellular sheets, methods of making and use thereof
JP3934539B2 (ja)	2001-12-12	2007-06-20	独立行政法人科学技術振興機構	胎盤等由来の成体又は生後組織の前駆細胞
US20030113910A1 (en) *	2001-12-18	2003-06-19	Mike Levanduski	Pluripotent stem cells derived without the use of embryos or fetal tissue
IL162648A0 (en) *	2001-12-21	2005-11-20	Mount Sinai Hospital Corp	Cellular compositions and methods of making and using them
US7101546B2 (en)	2001-12-21	2006-09-05	Amcyte, Inc.	In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
JP2005512593A (ja)	2001-12-28	2005-05-12	セルアーティスアーベー	多能性のヒト胚盤胞由来幹細胞株の樹立方法
AU2003202988A1 (en) *	2002-01-14	2003-07-30	The Board Of Trustees Of The University Of Illinois	Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US20030158089A1 (en)	2002-01-24	2003-08-21	Xenoport, Inc.	Administrative agents via the SMVT transporter
US20030162290A1 (en)	2002-01-25	2003-08-28	Kazutomo Inoue	Method for inducing differentiation of embryonic stem cells into functioning cells
AU2003217357A1 (en)	2002-02-07	2003-09-02	The Research Foundation Of The State University Of New York	Generation of new insulin cells from progenitor cells present in adult pancreatic islets
AU2003216286B2 (en) *	2002-02-13	2008-08-28	Celularity Inc.	Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US7576065B2 (en)	2002-02-15	2009-08-18	Cornell Research Foundation, Inc.	Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
AU2003215280A1 (en)	2002-02-15	2003-09-09	Northwestern University	Self-assembly of peptide-amphiphile nanofibers under physiological conditions
WO2003070922A1 (en)	2002-02-19	2003-08-28	Medipost Co., Ltd.	Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
WO2003072728A2 (en)	2002-02-22	2003-09-04	University Of Florida	Cellular trans-differentiation
US20030161818A1 (en)	2002-02-25	2003-08-28	Kansas State University Research Foundation	Cultures, products and methods using stem cells
US7736892B2 (en)	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
US7150990B2 (en)	2002-03-06	2006-12-19	Reprocell, Inc.	Self-renewing pluripotent hepatic stem cells
JP2003259862A (ja)	2002-03-12	2003-09-16	Fuji Photo Film Co Ltd	細胞培養担体
JPWO2003080822A1 (ja)	2002-03-27	2005-07-28	ニプロ株式会社	胎盤由来の間葉系細胞およびその医学的用途
US20050118715A1 (en)	2002-04-12	2005-06-02	Hariri Robert J.	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
JP4136434B2 (ja)	2002-04-17	2008-08-20	進清野	インスリン産生細胞の誘導
US20040161419A1 (en)	2002-04-19	2004-08-19	Strom Stephen C.	Placental stem cells and uses thereof
EP1497435A4 (en)	2002-04-19	2005-07-27	Univ Pittsburgh	STEM CELLS DERIVED FROM PLAZENTA AND THEIR USES
US20030228295A1 (en)	2002-04-25	2003-12-11	Svendsen Clive N.	Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
US20040029269A1 (en) *	2002-05-07	2004-02-12	Goldman Steven A	Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells
WO2003094965A2 (en) *	2002-05-08	2003-11-20	Neuronova Ab	Modulation of neural stem cells with s1p or lpa receptor agonists
BR0311360A (pt)	2002-05-28	2006-06-06	Becton Dickinson Co	métodos para expansão e transdiferenciação in vitro de células acinares pancreáticas humanas em células produtoras de insulina
CA2488013A1 (en)	2002-05-30	2003-12-11	Celgene Corporation	Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
WO2003104442A1 (en)	2002-06-07	2003-12-18	Es Cell International Pte Ltd	Methods of regulating differentiation in stem cells
US7410797B2 (en) *	2002-06-11	2008-08-12	Ogle Roy C	Meningeal-derived stem cells
AU2003279912A1 (en)	2002-06-27	2004-01-19	Northwestern University	Peptide rod amphiphiles and self-assembly of same
US7285415B2 (en) *	2002-07-11	2007-10-23	The Regents Of The University Of California	Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
GB0216286D0 (en)	2002-07-15	2002-08-21	Univ Leeds	Network
AU2003242976A1 (en) *	2002-07-16	2004-02-02	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Methods of implanting mesenchymal stem cells for tissue repair and formation
US7390659B2 (en)	2002-07-16	2008-06-24	The Trustees Of Columbia University In The City Of New York	Methods for inducing differentiation of embryonic stem cells and uses thereof
US20040110287A1 (en)	2002-07-29	2004-06-10	Es Cell International Pte Ltd.	Multi-step method for the differentiation of insulin positive, glucose responsive cells
AU2003250666A1 (en)	2002-07-29	2004-02-16	Asahi Kasei Kabushiki Kaisha	Stem cells for treating pancreatic damage
US20040063204A1 (en)	2002-08-14	2004-04-01	Lijun Yang	Bone marrow cell differentiation
AU2003265094A1 (en)	2002-08-26	2004-03-11	Neuronova Ab	Method for culturing stem cells
AU2003265856A1 (en)	2002-08-28	2004-03-19	University Of Florida	Neurogenesis from hepatic stem cells
JP2005537803A (ja)	2002-09-06	2005-12-15	アムサイトインコーポレーティッド	Ｃｄ５６陽性ヒト成体膵臓内分泌前駆細胞
US9969977B2 (en)	2002-09-20	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US6766863B2 (en) *	2002-09-20	2004-07-27	Hypro Corporation	Fire fighting foam injection system with auto-start feature
US20040062753A1 (en)	2002-09-27	2004-04-01	Alireza Rezania	Composite scaffolds seeded with mammalian cells
JP4262465B2 (ja) *	2002-10-24	2009-05-13	富士フイルム株式会社	細胞培養方法
AU2003287444A1 (en)	2002-10-31	2004-05-25	The General Hospital Corporation	Repairing or replacing tissues or organs
US20040258670A1 (en)	2002-12-05	2004-12-23	Case Western Reserve University	Cell-based therapies for ischemia
JP4571387B2 (ja) *	2003-02-07	2010-10-27	宣男櫻川	ヒト羊膜由来サイドポピュレーション細胞及びその用途
AU2004210853A1 (en)	2003-02-11	2004-08-26	Northwestern University	Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
JP4790592B2 (ja)	2003-02-11	2011-10-12	ダビース，ジヨン・イー	ヒト臍帯のウォートンジェリーからの前駆細胞
US7521481B2 (en) *	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
US20040224401A1 (en) *	2003-03-28	2004-11-11	Ludwig Tenneille E.	Physiochemical culture conditions for embryonic stem cells
EP1636351A4 (en)	2003-05-21	2007-04-04	Gen Hospital Corp	MICROFABRICATED COMPOSITIONS AND METHODS OF TISSUE GENIUS FOR OBTAINING TISSUES CONTAINING MULTIPLE CELLULAR TYPES
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
ES2552226T3 (es)	2003-06-27	2015-11-26	DePuy Synthes Products, Inc.	Reparación y regeneración de cartílago y hueso utilizando células derivadas posparto
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US20060223177A1 (en)	2003-06-27	2006-10-05	Ethicon Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
AU2004269409A1 (en)	2003-08-29	2005-03-10	Regents Of The University Of Minnesota	Kidney derived stem cells and methods for their isolation, differentiation and use
US20050089513A1 (en)	2003-10-28	2005-04-28	Norio Sakuragawa	Side population cells originated from human amnion and their uses
ATE486540T1 (de)	2003-12-23	2010-11-15	Fmc Biopolymer As	Verwendung von alginat-matrizen zur kontrolle des zellwachstums
TWI276685B (en)	2003-12-30	2007-03-21	Ind Tech Res Inst	Conditional medium for culturing Schwann cells
US7534606B2 (en)	2004-01-12	2009-05-19	National Health Research Institutes	Placental stem cell and methods thereof
DE102004043256B4 (de)	2004-09-07	2013-09-19	Rheinische Friedrich-Wilhelms-Universität Bonn	Skalierbarer Prozess zur Kultivierung undifferenzierter Stammzellen in Suspension
US8039258B2 (en) *	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
CA2585547A1 (en)	2004-10-29	2006-05-11	Centocor, Inc.	Chemically defined media compositions
US7655678B2 (en) *	2004-11-30	2010-02-02	Council of Scientfic & Industrial Research	Pharmaceutical composition for the management of tumors
WO2006101548A2 (en)	2004-12-21	2006-09-28	Ethicon, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060166361A1 (en)	2004-12-21	2006-07-27	Agnieszka Seyda	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060153815A1 (en)	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
CA2592435C (en)	2004-12-23	2017-03-28	DePuy Synthes Products, Inc.	Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
WO2006071773A2 (en)	2004-12-23	2006-07-06	Ethicon Incoporated	Treatment of osteochondral diseases using postpartum-derived cells and products thereof
EP1831355A2 (en)	2004-12-23	2007-09-12	Ethicon, Inc.	Soft tissue repair and regeneration using postpartum-derived cells and cell products
US7741311B2 (en)	2005-01-03	2010-06-22	Shaker Mousa	Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
EP1853698A1 (en)	2005-01-28	2007-11-14	NovaThera Ltd.	Methods for embryonic stem cell culture
CN103361302A (zh)	2005-03-31	2013-10-23	斯丹姆涅恩有限公司	从高度纯化来自羊膜的细胞群获得的细胞裂解产物的组合物
US7923007B2 (en)	2005-08-08	2011-04-12	Academia Sinica	Brain tissue damage therapies
JP5289970B2 (ja)	2005-12-16	2013-09-11	エシコン・インコーポレイテッド	組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
AU2006327073B2 (en)	2005-12-19	2012-08-30	Ethicon, Inc.	In vitro expansion of postpartum derived cells in roller bottles
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
EP1979050B1 (en)	2005-12-28	2017-04-19	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using postpartum-derived cells
ES2671355T3 (es)	2005-12-29	2018-06-06	Anthrogenesis Corporation	Poblaciones de células madre placentarias
JP5106416B2 (ja) *	2006-01-06	2012-12-26	アジレント・テクノロジーズ・インク	濃縮（ｐａｃｋｅｄ）ＤＮＡポリメラーゼを含む核酸複製のための反応緩衝液組成物
ES2549528T3 (es)	2006-03-23	2015-10-29	Pluristem Ltd.	Métodos de expansión de células y usos de células y de medios de acondicionamiento producidos por los mismos para terapia
WO2007146105A2 (en) *	2006-06-05	2007-12-21	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
DK2078073T3 (da)	2006-10-12	2013-10-28	Ethicon Inc	Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering
EP2089511B1 (en)	2006-11-13	2014-09-17	DePuy Synthes Products, LLC	In vitro expansion of postpartum-derived cells using microcarriers
SI2120977T1 (sl)	2007-02-12	2014-01-31	Anthrogenesis Coroporation	Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic
US20080305148A1 (en)	2007-03-19	2008-12-11	National Yang Ming University	Treatment of spinal injuries using human umbilical mesenchymal stem cells
CA2701435C (en)	2007-10-05	2017-06-20	Ethicon, Inc.	Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
US20090123620A1 (en) *	2007-11-14	2009-05-14	Hiti Thomas R	Automated Application of an Antimycotic Composition to Sliced Foodstuffs and an Antimycotic Application Apparatus
US8236538B2 (en)	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
US20090186358A1 (en) *	2007-12-21	2009-07-23	Wyeth	Pathway Analysis of Cell Culture Phenotypes and Uses Thereof
ES2621610T3 (es)	2007-12-27	2017-07-04	DePuy Synthes Products, Inc.	Tratamiento de la degeneración de discos intervertebrales utilizando células derivadas de tejido cordón umbilical humano
TWI387135B (zh) *	2008-03-28	2013-02-21	財團法人工業技術研究院	發光裝置及其製造方法
AU2009327383B2 (en)	2008-12-19	2014-08-28	DePuy Synthes Products, LLC	Regeneration and repair of neural tissue following injury
CN107028983A (zh)	2008-12-19	2017-08-11	德普伊新特斯产品有限责任公司	肺部疾病和病症的治疗
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
JP5646502B2 (ja)	2008-12-19	2014-12-24	デピュイ・シンセス・プロダクツ・エルエルシーＤｅＰｕｙＳｙｎｔｈｅｓＰｒｏｄｕｃｔｓ，ＬＬＣ	神経因性疼痛を治療するための臍帯組織由来細胞
US8722034B2 (en)	2009-03-26	2014-05-13	Depuy Synthes Products Llc	hUTC as therapy for Alzheimer's disease
KR20140018876A (ko) *	2011-01-19	2014-02-13	이 아이 듀폰 디 네모아 앤드 캄파니	폐쇄 기능을 가진 리튬 배터리 격리판

2004
- 2004-06-25 ES ES10183911.6T patent/ES2552226T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP10184306.8A patent/EP2338982B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517783A patent/JP5148873B2/ja not_active Expired - Fee Related
- 2004-06-25 ES ES10184593.1T patent/ES2542070T3/es not_active Expired - Lifetime
- 2004-06-25 CA CA2530732A patent/CA2530732C/en not_active Expired - Fee Related
- 2004-06-25 WO PCT/US2004/020822 patent/WO2005001077A2/en not_active Ceased
- 2004-06-25 WO PCT/US2004/020956 patent/WO2005001079A2/en not_active Ceased
- 2004-06-25 ES ES04777286.8T patent/ES2582342T3/es not_active Expired - Lifetime
- 2004-06-25 PL PL10184137T patent/PL2338980T3/pl unknown
- 2004-06-25 ES ES10183053.7T patent/ES2550267T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP04756395.2A patent/EP1641913B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL10183053T patent/PL2399990T3/pl unknown
- 2004-06-25 WO PCT/US2004/020816 patent/WO2005001076A2/en not_active Ceased
- 2004-06-25 PL PL10184796T patent/PL2336298T3/pl unknown
- 2004-06-25 AU AU2004252567A patent/AU2004252567B2/en not_active Ceased
- 2004-06-25 ES ES04777231.4T patent/ES2597837T3/es not_active Expired - Lifetime
- 2004-06-25 CA CA2530533A patent/CA2530533C/en not_active Expired - Fee Related
- 2004-06-25 WO PCT/US2004/020957 patent/WO2005001080A2/en not_active Ceased
- 2004-06-25 ES ES10184137.7T patent/ES2542069T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES04777287.6T patent/ES2564045T3/es not_active Expired - Lifetime
- 2004-06-25 US US10/877,446 patent/US9579351B2/en not_active Expired - Fee Related
- 2004-06-25 PL PL04809466T patent/PL1649013T3/pl unknown
- 2004-06-25 WO PCT/US2004/020931 patent/WO2005003334A2/en not_active Ceased
- 2004-06-25 EP EP04809466.8A patent/EP1649013B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530255A patent/CA2530255C/en not_active Expired - Fee Related
- 2004-06-25 EP EP04777231.4A patent/EP1641914B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530412A patent/CA2530412C/en not_active Expired - Fee Related
- 2004-06-25 WO PCT/US2004/020958 patent/WO2005038012A2/en not_active Ceased
- 2004-06-25 US US10/877,009 patent/US7560276B2/en not_active Expired - Lifetime
- 2004-06-25 EP EP10183053.7A patent/EP2399990B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517760A patent/JP4950661B2/ja not_active Expired - Fee Related
- 2004-06-25 EP EP20100184221 patent/EP2338981B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530416A patent/CA2530416C/en not_active Expired - Fee Related
- 2004-06-25 EP EP04777286.8A patent/EP1641917B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530422A patent/CA2530422C/en not_active Expired - Fee Related
- 2004-06-25 JP JP2006517787A patent/JP4948165B2/ja not_active Expired - Fee Related
- 2004-06-25 US US10/877,012 patent/US7510873B2/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517786A patent/JP4948164B2/ja not_active Expired - Fee Related
- 2004-06-25 AU AU2004281371A patent/AU2004281371C1/en not_active Ceased
- 2004-06-25 JP JP2006517757A patent/JP4950659B2/ja not_active Expired - Fee Related
- 2004-06-25 AU AU2004252566A patent/AU2004252566B2/en not_active Ceased
- 2004-06-25 ES ES04777235.5T patent/ES2568463T3/es not_active Expired - Lifetime
- 2004-06-25 US US10/877,445 patent/US8703121B2/en active Active
- 2004-06-25 EP EP04777287.6A patent/EP1641918B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL04777286.8T patent/PL1641917T3/pl unknown
- 2004-06-25 ES ES04777234.8T patent/ES2600555T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP10184796.0A patent/EP2336298B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517759A patent/JP4950660B2/ja not_active Expired - Fee Related
- 2004-06-25 US US10/877,269 patent/US7524489B2/en not_active Expired - Lifetime
- 2004-06-25 ES ES04756395.2T patent/ES2564044T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES10184306.8T patent/ES2554343T3/es not_active Expired - Lifetime
- 2004-06-25 PL PL04777287T patent/PL1641918T3/pl unknown
- 2004-06-25 PL PL10183911T patent/PL2341131T3/pl unknown
- 2004-06-25 EP EP20100184137 patent/EP2338980B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL04777231T patent/PL1641914T3/pl unknown
- 2004-06-25 EP EP04777234.8A patent/EP1641915B1/en not_active Expired - Lifetime
- 2004-06-25 EP EP10184593.1A patent/EP2322599B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL10184306T patent/PL2338982T3/pl unknown
- 2004-06-25 JP JP2006517788A patent/JP4948166B2/ja not_active Expired - Fee Related
- 2004-06-25 PL PL04777234T patent/PL1641915T3/pl unknown
- 2004-06-25 WO PCT/US2004/020823 patent/WO2005001078A2/en not_active Ceased
- 2004-06-25 PL PL04756395T patent/PL1641913T3/pl unknown
- 2004-06-25 PL PL10184221T patent/PL2338981T3/pl unknown
- 2004-06-25 EP EP10183911.6A patent/EP2341131B1/en not_active Expired - Lifetime
- 2004-06-25 ES ES04809466.8T patent/ES2565582T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP04777235.5A patent/EP1641916B1/en not_active Expired - Lifetime
- 2004-06-25 AU AU2004252568A patent/AU2004252568B2/en not_active Expired - Fee Related
- 2004-06-25 ES ES10184221.9T patent/ES2541604T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES10184796.0T patent/ES2569780T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004252571A patent/AU2004252571C1/en not_active Ceased
- 2004-06-25 PL PL10184593T patent/PL2322599T3/pl unknown
- 2004-06-25 CA CA2530421A patent/CA2530421C/en not_active Expired - Fee Related
- 2004-06-25 US US10/877,541 patent/US7413734B2/en not_active Expired - Lifetime
- 2004-06-25 AU AU2004254616A patent/AU2004254616C1/en not_active Ceased
- 2004-06-25 PL PL04777235T patent/PL1641916T3/pl unknown
- 2004-06-25 AU AU2004252570A patent/AU2004252570C1/en not_active Ceased
- 2004-06-25 US US10/876,998 patent/US11191789B2/en not_active Expired - Fee Related
2005
- 2005-12-22 US US11/316,104 patent/US9504719B2/en not_active Expired - Fee Related
- 2005-12-22 US US11/315,969 patent/US11179422B2/en not_active Expired - Fee Related
- 2005-12-23 US US11/317,574 patent/US20060234376A1/en not_active Abandoned
- 2005-12-29 US US11/321,863 patent/US20060153817A1/en not_active Abandoned
- 2005-12-29 US US11/322,003 patent/US20060154367A1/en not_active Abandoned
- 2005-12-29 US US11/321,864 patent/US20060153818A1/en not_active Abandoned
- 2005-12-30 US US11/322,372 patent/US20060188983A1/en not_active Abandoned
2006
- 2006-07-06 US US11/481,481 patent/US20070014771A1/en not_active Abandoned
- 2006-07-06 US US11/481,480 patent/US20070009494A1/en not_active Abandoned
- 2006-07-06 US US11/481,456 patent/US8318483B2/en not_active Expired - Fee Related
2009
- 2009-02-19 US US12/389,305 patent/US9498501B2/en not_active Expired - Fee Related
- 2009-04-24 US US12/429,849 patent/US8277796B2/en not_active Expired - Fee Related
2012
- 2012-09-06 US US13/605,716 patent/US8658152B2/en not_active Expired - Lifetime
2013
- 2013-09-05 US US14/018,842 patent/US9717763B2/en not_active Expired - Fee Related
2016
- 2016-11-28 US US15/362,453 patent/US10039793B2/en not_active Expired - Lifetime
2017
- 2017-02-27 US US15/443,733 patent/US10383898B2/en not_active Expired - Fee Related
- 2017-02-27 US US15/443,718 patent/US10195233B2/en not_active Expired - Lifetime
- 2017-02-27 US US15/443,602 patent/US10220059B2/en not_active Expired - Lifetime
- 2017-07-27 US US15/661,878 patent/US10500234B2/en not_active Expired - Fee Related
2018
- 2018-08-06 US US16/056,146 patent/US10758576B2/en not_active Expired - Fee Related
2019
- 2019-03-04 US US16/291,784 patent/US11000554B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2530732A1 (en)	2005-01-06
US8703121B2 (en)	2014-04-22
US20070014771A1 (en)	2007-01-18
CA2530416C (en)	2015-08-25
US7413734B2 (en)	2008-08-19
EP2399990A1 (en)	2011-12-28
EP2341131A2 (en)	2011-07-06
ES2569780T3 (es)	2016-05-12
PL1649013T3 (pl)	2016-07-29
EP1641914B1 (en)	2016-07-20
US20070009494A1 (en)	2007-01-11
US9717763B2 (en)	2017-08-01
US8277796B2 (en)	2012-10-02
US20190192577A1 (en)	2019-06-27
EP2338982A3 (en)	2011-08-03
JP2007528703A (ja)	2007-10-18
JP4950661B2 (ja)	2012-06-13
AU2004254616B2 (en)	2011-09-01
EP2399990B1 (en)	2015-07-22
JP2007521009A (ja)	2007-08-02
ES2568463T3 (es)	2016-04-29
EP2341131A3 (en)	2011-08-03
CA2530422C (en)	2016-01-05
EP1641916A2 (en)	2006-04-05
EP1649013B1 (en)	2016-01-20
US20170326183A1 (en)	2017-11-16
US8658152B2 (en)	2014-02-25
WO2005001076A3 (en)	2005-03-31
WO2005001078A3 (en)	2005-04-21
US11000554B2 (en)	2021-05-11
ES2564044T3 (es)	2016-03-17
ES2582342T3 (es)	2016-09-12
US20060153816A1 (en)	2006-07-13
JP2007521793A (ja)	2007-08-09
AU2004252568B2 (en)	2011-06-30
AU2004254616C1 (en)	2012-03-01
AU2004252568A1 (en)	2005-01-06
US20050019865A1 (en)	2005-01-27
EP1641917B1 (en)	2016-04-27
EP2322599A3 (en)	2011-07-27
US20050054098A1 (en)	2005-03-10
WO2005001080A3 (en)	2005-03-24
US10220059B2 (en)	2019-03-05
US10500234B2 (en)	2019-12-10
EP2322599A2 (en)	2011-05-18
CA2530421A1 (en)	2005-01-06
US20170166863A1 (en)	2017-06-15
ES2542070T3 (es)	2015-07-30
EP2341131B1 (en)	2015-08-05
ES2564045T3 (es)	2016-03-17
US11191789B2 (en)	2021-12-07
US20180338999A1 (en)	2018-11-29
AU2004252570C1 (en)	2012-03-01
AU2004281371A1 (en)	2005-04-28
ES2600555T3 (es)	2017-02-09
EP1641913A2 (en)	2006-04-05
AU2004252567A1 (en)	2005-01-06
JP2007528706A (ja)	2007-10-18
US20100260843A1 (en)	2010-10-14
CA2530412A1 (en)	2005-04-28
US20050058630A1 (en)	2005-03-17
EP2336298B1 (en)	2016-02-17
ES2550267T3 (es)	2015-11-05
EP1641913B1 (en)	2016-01-06
US20140045263A1 (en)	2014-02-13
JP2007528702A (ja)	2007-10-18
EP1641914A2 (en)	2006-04-05
WO2005001077A2 (en)	2005-01-06
US9579351B2 (en)	2017-02-28
CA2530255C (en)	2015-12-08
ES2542069T3 (es)	2015-07-30
PL2341131T3 (pl)	2016-01-29
AU2004281371C1 (en)	2012-10-11
US9498501B2 (en)	2016-11-22
AU2004254616A1 (en)	2005-01-13
WO2005038012A3 (en)	2005-09-15
AU2004252571A1 (en)	2005-01-06
WO2005003334A3 (en)	2005-04-07
JP5148873B2 (ja)	2013-02-20
PL2338980T3 (pl)	2016-04-29
US20170143770A1 (en)	2017-05-25
AU2004252571B2 (en)	2011-09-15
EP2338981A3 (en)	2011-08-03
US10195233B2 (en)	2019-02-05
JP2007521008A (ja)	2007-08-02
ES2552226T3 (es)	2015-11-26
JP4950659B2 (ja)	2012-06-13
PL1641914T3 (pl)	2017-01-31
CA2530416A1 (en)	2005-01-06
PL2338981T3 (pl)	2016-01-29
AU2004252571C1 (en)	2012-03-01
EP1641915A2 (en)	2006-04-05
EP1649013A2 (en)	2006-04-26
US8318483B2 (en)	2012-11-27
EP2336298A3 (en)	2011-08-03
CA2530533C (en)	2015-02-10
ES2554343T3 (es)	2015-12-18
EP2338980A3 (en)	2011-08-10
PL1641918T3 (pl)	2016-06-30
US20050037491A1 (en)	2005-02-17
US20050058629A1 (en)	2005-03-17
US20060188983A1 (en)	2006-08-24
JP2007528705A (ja)	2007-10-18
US20060153818A1 (en)	2006-07-13
EP2336298A2 (en)	2011-06-22
AU2004281371B2 (en)	2012-05-10
CA2530412C (en)	2016-02-09
AU2004252570B2 (en)	2011-09-15
EP1641915B1 (en)	2016-07-27
EP2338981B1 (en)	2015-04-22
JP4948164B2 (ja)	2012-06-06
WO2005038012A2 (en)	2005-04-28
WO2005003334A2 (en)	2005-01-13
WO2005001080A2 (en)	2005-01-06
EP2322599B1 (en)	2015-04-15
EP2338980A2 (en)	2011-06-29
PL2322599T3 (pl)	2015-10-30
US20060153817A1 (en)	2006-07-13
AU2004252570A1 (en)	2005-01-06
US10039793B2 (en)	2018-08-07
US20070036767A1 (en)	2007-02-15
EP1641918A2 (en)	2006-04-05
US20050058631A1 (en)	2005-03-17
US20170166864A1 (en)	2017-06-15
US20130022585A1 (en)	2013-01-24
WO2005001076A2 (en)	2005-01-06
PL1641917T3 (pl)	2016-11-30
EP2338980B1 (en)	2015-04-22
JP4948166B2 (ja)	2012-06-06
JP4950660B2 (ja)	2012-06-13
ES2541604T3 (es)	2015-07-22
WO2005001078A2 (en)	2005-01-06
EP2338982B1 (en)	2015-08-26
US20060234376A1 (en)	2006-10-19
EP1641917A2 (en)	2006-04-05
ES2565582T3 (es)	2016-04-05
CA2530421C (en)	2015-04-21
PL1641913T3 (pl)	2016-06-30
US7524489B2 (en)	2009-04-28
AU2004252567B2 (en)	2011-10-06
US20050032209A1 (en)	2005-02-10
EP1641916B1 (en)	2016-02-17
CA2530255A1 (en)	2005-01-06
WO2005001079A2 (en)	2005-01-06
AU2004252566B2 (en)	2011-09-15
US7560276B2 (en)	2009-07-14
EP2338982A2 (en)	2011-06-29
PL2338982T3 (pl)	2016-01-29
CA2530422A1 (en)	2005-01-06
US20060154367A1 (en)	2006-07-13
US9504719B2 (en)	2016-11-29
PL1641915T3 (pl)	2017-01-31
JP4948165B2 (ja)	2012-06-06
CA2530533A1 (en)	2005-01-13
US20060154366A1 (en)	2006-07-13
ES2597837T3 (es)	2017-01-23
US10758576B2 (en)	2020-09-01
US7510873B2 (en)	2009-03-31
WO2005001079A3 (en)	2005-04-28
US20170239299A1 (en)	2017-08-24
PL1641916T3 (pl)	2016-08-31
CA2530732C (en)	2015-03-31
EP2338981A2 (en)	2011-06-29
US10383898B2 (en)	2019-08-20
WO2005001077A3 (en)	2005-03-03
AU2004252566A1 (en)	2005-01-06
PL2336298T3 (pl)	2016-08-31
EP1641918B1 (en)	2016-01-06
US20100210013A1 (en)	2010-08-19
US11179422B2 (en)	2021-11-23

Publication	Publication Date	Title
PL2399990T3 (pl)	2015-12-31	Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia
IL291162A (en)	2022-05-01	Isolated human rpe cells and their use for the treatment of retinal degenerative diseases
EP1638624A4 (en)	2011-03-09	MEDICAL DEVICES AND METHOD FOR REGULATING THE TISSUE RESPONSE TO VASCULAR DEVICES
EP1641378A4 (en)	2009-08-26	METHOD AND DEVICES FOR TREATING SKIN Lions
EP1599122A4 (en)	2009-04-29	SYSTEM AND METHOD FOR NON-FEVER TISSUE CHARACTERIZATION
EP1680166A4 (en)	2010-08-25	METHOD AND DEVICE FOR THE TREATMENT OF HEART FAILURE
WO2011056578A3 (en)	2011-09-15	Ventricular volume reduction
AU2003295325A8 (en)	2004-11-26	Heart bypass system incorporating minimized extracorporeal blood circulation system and related method of use
AU2003251567A8 (en)	2004-01-06	Dialysis system for treatment of vulnerable patients and methods of use
IL178142A0 (en)	2006-12-31	Methods of using and compositions comprising immunomodulatory compounos for the treatment and management of skin diseases or disorders
SI1546088T1 (sl)	2015-04-30	Spojine za uporabo v zdravljenju avtoimunskih bolezni, imunoalergijskih bolezni in zavrnitve transpalantata organa ali tkiva
EP1708757A4 (en)	2007-01-17	USE OF PLURIPOTENTIAL CELLS TAKEN FROM HUMAN CORDIAL BLOOD BLOOD FOR THE TREATMENT OF DISEASE
AU2003296379A8 (en)	2004-06-30	Methods and devices for cardiac surgery
EP1689284A4 (en)	2010-03-17	METHOD FOR REGULATING VENTRICULAR RHYTHM IN AURICULAR FIBRILLATION PATIENTS
AU2003291536A8 (en)	2004-06-15	Method for the diagnosis and treatment of vascular disease
AU2003219462A8 (en)	2003-11-11	Defibrillator/monitor with patient specific treatment algorithms
IL176027A0 (en)	2006-10-05	Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
EP1838260A4 (en)	2011-05-25	SYSTEM AND METHOD FOR TREATMENT OF CARDIAC TISSUE
IL179560A0 (en)	2007-05-15	Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
AU2002322301A1 (en)	2003-03-03	Methods for the diagnosis and treatment of cardiac tissue rejection
GB0300428D0 (en)	2003-02-05	Medical treatment
ZA200610297B (en)	2008-10-29	Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
GB0316940D0 (en)	2003-08-27	Treatment of skin and other medical conditions
IL160391A0 (en)	2004-07-25	System and method for ventricular pacing of the heart
IL166046A0 (en)	2006-01-15	System and method for ventricular pacing of the heart